<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<!-- saved from url=(0052)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/ -->
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3056523/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Accurate Prediction of Dose-Dependent CYP3A4 Inhibition by Itraconazole and Its Metabolites From In Vitro Inhibition Data</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="./PMC3056523_files/jig.min.css"><script type="text/javascript" src="./PMC3056523_files/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Clinical pharmacology and therapeutics"><meta name="citation_title" content="Accurate Prediction of Dose-Dependent CYP3A4 Inhibition by Itraconazole and Its Metabolites From In Vitro Inhibition Data"><meta name="citation_authors" content="I Templeton, C-C Peng, KE Thummel, C Davis, KL Kunze, N Isoherranen"><meta name="citation_date" content="October 2010"><meta name="citation_issue" content="4"><meta name="citation_volume" content="88"><meta name="citation_firstpage" content="499"><meta name="citation_doi" content="10.1038/clpt.2010.119"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3056523/?report=abstract"><meta name="citation_pmid" content="20739919"><meta name="DC.Title" content="Accurate Prediction of Dose-Dependent CYP3A4 Inhibition by Itraconazole and Its Metabolites From In Vitro Inhibition Data"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="I Templeton"><meta name="DC.Contributor" content="C-C Peng"><meta name="DC.Contributor" content="KE Thummel"><meta name="DC.Contributor" content="C Davis"><meta name="DC.Contributor" content="KL Kunze"><meta name="DC.Contributor" content="N Isoherranen"><meta name="DC.Date" content="2010 Oct"><meta name="DC.Identifier" content="10.1038/clpt.2010.119"><meta name="DC.Language" content="en"><meta property="og:title" content="Accurate Prediction of Dose-Dependent CYP3A4 Inhibition by Itraconazole and Its Metabolites From In Vitro Inhibition Data"><meta property="og:type" content="article"><meta property="og:description" content="Inhibitory drug metabolites may contribute to drug–drug interactions (DDIs). The aim of this study was to determine the importance of inhibitory metabolites of itraconazole (ITZ) in in vivo cytochrome p450 (CYP) 3A4 inhibition. The pharmacokinetics ..."><meta property="og:url" content="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="http://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="./PMC3056523_files/pmc.min.css" type="text/css"><link rel="stylesheet" href="./PMC3056523_files/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="./PMC3056523_files/common.min.js">//</script><script type="text/javascript" src="./PMC3056523_files/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:&#39;/pmc/utils/ctxp/&#39;"><script type="text/javascript" src="./PMC3056523_files/jquery.citationexporter.js">//</script><link rel="stylesheet" href="./PMC3056523_files/citationexporter.css" type="text/css"><script type="text/javascript" src="./PMC3056523_files/MathJax.js"></script><script type="text/javascript" src="./PMC3056523_files/large-obj-scrollbars.min.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><link rel="alternate" type="application/epub+zip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/epub/"><link rel="alternate" type="application/pdf" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/pdf/nihms-268021.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="http://www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="8A1A793276C277A1000000000079CAC7"><link type="text/css" rel="stylesheet" href="./PMC3056523_files/3855312.css"><link type="text/css" rel="stylesheet" href="./PMC3056523_files/3929378.css" media="print"><style type="text/css" media="print">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }.print-log li { list-style-image: url('http://www.ncbi.nlm.nih.gov/stat?jsevent=print&ncbi_app=pmc&ncbi_db=pmc&ncbi_pcid=%2Farticles%2FPMC3056523%2F&ncbi_pdid=article&ncbi_phid=8A1A793276C277A1000000000079CAC7'); }</style><style type="text/css">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }</style><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style><style type="text/css">.MathJax_Display {text-align: center; margin: 1em 0em; position: relative; display: block!important; text-indent: 0; max-width: none; max-height: none; min-width: 0; min-height: 0; width: 100%}
.MathJax .merror {background-color: #FFFF88; color: #CC0000; border: 1px solid #CC0000; padding: 1px 3px; font-style: normal; font-size: 90%}
.MathJax .MJX-monospace {font-family: monospace}
.MathJax .MJX-sans-serif {font-family: sans-serif}
#MathJax_Tooltip {background-color: InfoBackground; color: InfoText; border: 1px solid black; box-shadow: 2px 2px 5px #AAAAAA; -webkit-box-shadow: 2px 2px 5px #AAAAAA; -moz-box-shadow: 2px 2px 5px #AAAAAA; -khtml-box-shadow: 2px 2px 5px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true'); padding: 3px 4px; z-index: 401; position: absolute; left: 0; top: 0; width: auto; height: auto; display: none}
.MathJax {display: inline; font-style: normal; font-weight: normal; line-height: normal; font-size: 100%; font-size-adjust: none; text-indent: 0; text-align: left; text-transform: none; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; direction: ltr; max-width: none; max-height: none; min-width: 0; min-height: 0; border: 0; padding: 0; margin: 0}
.MathJax:focus, body :focus .MathJax {display: inline-table}
.MathJax img, .MathJax nobr, .MathJax a {border: 0; padding: 0; margin: 0; max-width: none; max-height: none; min-width: 0; min-height: 0; vertical-align: 0; line-height: normal; text-decoration: none}
img.MathJax_strut {border: 0!important; padding: 0!important; margin: 0!important; vertical-align: 0!important}
.MathJax span {display: inline; position: static; border: 0; padding: 0; margin: 0; vertical-align: 0; line-height: normal; text-decoration: none}
.MathJax nobr {white-space: nowrap!important}
.MathJax img {display: inline!important; float: none!important}
.MathJax * {transition: none; -webkit-transition: none; -moz-transition: none; -ms-transition: none; -o-transition: none}
.MathJax_Processing {visibility: hidden; position: fixed; width: 0; height: 0; overflow: hidden}
.MathJax_Processed {display: none!important}
.MathJax_ExBox {display: block!important; overflow: hidden; width: 1px; height: 60ex; min-height: 0; max-height: none}
.MathJax .MathJax_EmBox {display: block!important; overflow: hidden; width: 1px; height: 60em; min-height: 0; max-height: none}
.MathJax .MathJax_HitBox {cursor: text; background: white; opacity: 0; filter: alpha(opacity=0)}
.MathJax .MathJax_HitBox * {filter: none; opacity: 1; background: transparent}
#MathJax_Tooltip * {filter: none; opacity: 1; background: transparent}
@font-face {font-family: MathJax_Blank; src: url('about:blank')}
</style></head>
    <body class="article" id="ui-jig-5"><div style="visibility: hidden; overflow: hidden; position: absolute; top: 0px; height: 1px; width: auto; padding: 0px; border: 0px; margin: 0px; text-align: left; text-indent: 0px; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal;"><div id="MathJax_Hidden"></div></div><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	&lt;p class="nojs"&gt;
	&lt;strong&gt;Warning:&lt;/strong&gt;
	The NCBI web site requires JavaScript to function. 
	&lt;a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank"&gt;more...&lt;/a&gt;
	&lt;/p&gt;
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="http://www.ncbi.nlm.nih.gov/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="./PMC3056523_files/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="http://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="http://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="http://www.ncbi.nlm.nih.gov/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="http://www.ncbi.nlm.nih.gov/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="http://www.ncbi.nlm.nih.gov/account/?back_url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3056523%2F" id="sign_in">Sign in to NCBI</a><a href="http://www.ncbi.nlm.nih.gov/account/signout/?back_url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3056523%2F" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="http://www.ncbi.nlm.nih.gov/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="http://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="http://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="http://www.ncbi.nlm.nih.gov/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="clone">Clone</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="nucest">EST</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="nucgss">GSS</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="pubmedhealth">PubMed Health</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbook">ToolKitBook</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="ui-ncbiclearbutton-wrap box-shadow"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" config="dictionary:&#39;pmc-search-autocomplete&#39;,disableUrl:&#39;NcbiSearchBarAutoComplCtrl&#39;" autocomplete="off" data-sbconfig="ds:&#39;no&#39;,pjs:&#39;no&#39;,afs:&#39;yes&#39;" aria-haspopup="true" aria-autocomplete="list" role="textbox"><a class="reset" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" style="visibility: hidden;"><img src="./PMC3056523_files/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/limits/">Limits</a>
                    </li><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="http://www.ncbi.nlm.nih.gov/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="http://www.ncbi.nlm.nih.gov/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="http://www.ncbi.nlm.nih.gov/pmc/?term=hhs%20author%20manuscript[filter]&amp;cmd=search&amp;EntrezSystem2.PEntrez.Pmc.Pmc_LimitsTab.LimitsOff=true" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC3056523</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="./PMC3056523_files/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="http://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="http://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="http://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="http://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [&#39;h2&#39;], headingExclude: &#39;:hidden&#39;" id="ui-jig-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="small"><div class="inline_block eight_col va_top"><div>Clin Pharmacol Ther. Author manuscript; available in PMC 2011 Mar 14.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=20739919" target="pmc_ext" ref="reftype=publisher&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access&amp;rendering-type=normal"><span class="cit">Clin Pharmacol Ther. 2010 Oct; 88(4): 499–505. </span></a></div><span class="fm-vol-iss-date">Published online 2010 Aug 25. </span> <span class="doi">doi:&nbsp; <a href="http://dx.doi.org/10.1038%2Fclpt.2010.119" target="pmc_ext" ref="reftype=other&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">10.1038/clpt.2010.119</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3056523</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS268021</span></div></div></div></div></div><h1 class="content-title">Accurate Prediction of Dose-Dependent CYP3A4 Inhibition by Itraconazole and Its Metabolites From <em>In Vitro</em> Inhibition Data</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Templeton%20I%5Bauth%5D">I Templeton</a>,<sup>1</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Peng%20CC%5Bauth%5D">C-C Peng</a>,<sup>1</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Thummel%20K%5Bauth%5D">KE Thummel</a>,<sup>1</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Davis%20C%5Bauth%5D">C Davis</a>,<sup>2</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kunze%20K%5Bauth%5D">KL Kunze</a>,<sup>3</sup> and  <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Isoherranen%20N%5Bauth%5D">N Isoherranen</a><sup>1</sup></div></div><div class="fm-panel small half_rhythm"><div class="fm-authors-info fm-panel hide half_rhythm" id="id369801_ai" style="display:none"><div class="fm-affl" lang="en"><sup>1</sup>Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington, USA </div><div class="fm-affl" lang="en"><sup>2</sup>Division of Nephrology, Department of Medicine, School of Medicine, University of Washington, Seattle, Washington, USA </div><div class="fm-affl" lang="en"><sup>3</sup>Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, Washington, USA. </div><div id="CR1">Correspondence: N Isoherranen (<span class="before-email-separator"></span><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.notgnihsaw.u@2in" class="oemail">ude.notgnihsaw.u@2in</a>)</div></div><div class="togglers"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" class="pmctoggle" rid="id369801_ai">Author information <span>►</span></a> <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" class="pmctoggle" rid="id369801_cpl">Copyright and License information <span>►</span></a></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="fm-cpl-info fm-panel hide half_rhythm" id="id369801_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="http://www.ncbi.nlm.nih.gov/pmc/about/copyright.html">Copyright notice</a>  and <a href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html">Disclaimer</a></div></div></div><div class="links-box fm-panel whole_rhythm"><div class="small"><div>The publisher's final edited version of this article is available  at <a href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=20739919" target="pmc_ext" ref="reftype=publisher&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access&amp;rendering-type=normal">Clin Pharmacol Ther</a></div><div>See other articles in PMC that <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="__abstractid690938" lang="en" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-7"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true" id="ui-jig-8">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__abstractid690938title">Abstract</h2><!--article-meta--><div><p id="P1" class="p p-first-last">Inhibitory drug metabolites may contribute to drug–drug interactions (DDIs). The aim of this study was to determine the importance of inhibitory metabolites of itraconazole (ITZ) in <em>in vivo</em> cytochrome p450 (CYP) 3A4 inhibition. The pharmacokinetics of ITZ and midazolam (MDZ) were determined in six healthy volunteers in four sessions after administration of MDZ with and without oral ITZ. After doses of 50, 200, and 400 mg of ITZ, the clearance of orally administered MDZ decreased by 27, 74, and 83%, respectively. The <em>in vivo</em> half maximal inhibitory concentration (IC<sub>50</sub>) for ITZ ranged from 5 to 132 nmol/l in the six subjects. The metabolites of ITZ were estimated to account for ~50% of the total CYP3A4 inhibition, with the relative contribution increasing with time after ITZ dosing. Of the total of 18 interactions observed, 15 (84%) could be predicted within a twofold error margin, with improved accuracy observed when ITZ metabolites were included in the predictions. This study shows that the metabolites of ITZ contribute to CYP3A4 inhibition and need to be accounted for in quantitative rationalization of ITZ-mediated DDIs.</p></div></div><div id="__bodyid683848" class="tsec sec headless whole_rhythm"><p id="P2" class="p p-first">Many clinically important cytochrome P450 (CYP) inhibitors have been shown to possess circulating metabolites,<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946196" role="button" aria-expanded="false" aria-haspopup="true">1</a></sup> and many of these metabolites are predicted to contribute to <em>in vivo</em> drug–drug interactions (DDIs).<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R2" rid="R2" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">2</a></sup> Classic examples of inhibitors with circulating inhibitory metabolites include three potent CYP inhibitors: itraconazole (ITZ),<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946209" role="button" aria-expanded="false" aria-haspopup="true">3</a></sup> fluoxetine,<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946201" role="button" aria-expanded="false" aria-haspopup="true">4</a></sup> and bupropion.<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946193" role="button" aria-expanded="false" aria-haspopup="true">5</a></sup> Norfluoxetine, the primary circulating metabolite of fluoxetine, has been shown to be responsible for the persistent CYP2D6 inhibition after administration of fluoxetine,<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946212" role="button" aria-expanded="false" aria-haspopup="true">6</a></sup> although no quantitative prediction of CYP2D6 inhibition by norfluoxetine as compared with fluoxetine was shown. Using atomoxetine as an example, quantitative predictions of the contribution of metabolites to <em>in vivo</em> DDIs were performed, and, despite the overall weak <em>in vivo</em> inhibition of CYP3A4 and CYP2D6 by atomoxetine, the metabolites were predicted to be mainly responsible for the interaction.<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946191" role="button" aria-expanded="false" aria-haspopup="true">7</a></sup></p><p id="P3" class="p">The metabolites of ITZ have been predicted to account for ~50% of the overall CYP3A4 inhibition <em>in vivo</em>. This prediction is based on <em>in vivo</em> disposition data of ITZ and its three metabolites after a 100-mg dose of ITZ.<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_286160540" role="button" aria-expanded="false" aria-haspopup="true">8</a></sup> However, the inhibitory metabolites of ITZ, namely hydroxy-ITZ (OH-ITZ), keto-ITZ (keto-ITZ), and N-desalkyl ITZ (ND-ITZ) have not been measured <em>in vivo</em> simultaneously with CYP3A4 inhibition. Given the partially dissociative sequential metabolism of ITZ by CYP3A4 <em>in vitro</em><sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946194" role="button" aria-expanded="false" aria-haspopup="true">3</a></sup> and saturable <em>in vivo</em> clearance with escalating doses, it is likely that metabolite-to-parent ratios of ITZ decrease with increasing doses. Hence, if metabolites contribute significantly to <em>in vivo</em> CYP3A4 inhibition by ITZ, a dose-dependent underprediction of <em>in vivo</em> interactions would be expected when ITZ alone is considered in predictions. The aim of this study was to determine whether metabolites of ITZ contribute significantly to <em>in vivo</em> CYP3A4 inhibition and whether CYP3A4 inhibition by ITZ can be accurately predicted after administering escalating doses of ITZ. The concentrations of the inhibitors were measured in each subject, together with CYP3A4 activity. The individual <em>in vivo</em> half maximal inhibitory concentration (IC<sub>50</sub>) values were calculated, and the predicted and observed magnitudes of interaction were compared in each of the six study subjects.</p></div><div id="S1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-9"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-10">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S1title">RESULTS</h2><p id="P4" class="p p-first">Six healthy volunteers (one woman and five men), in the age range of 22–42 (mean 34) years and within 20% of optimal body mass index, completed the study. An additional female subject was enrolled, but she withdrew after the midazolam (MDZ) control session because of nausea and vomiting. No other side effects or possible adverse effects were observed in any of the subjects. All subjects had normal liver and kidney function and were in good health. Each subject was homozygous for CYP3A5*3 and hence was expected to lack expression of functional CYP3A5 protein. Individuals with potential CYP3A5 expression based on genotype were excluded from the study because CYP3A5 has been shown not to metabolize ITZ.<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946204" role="button" aria-expanded="false" aria-haspopup="true">3</a></sup></p><p id="P5">MDZ pharmacokinetics were measured after escalating doses of ITZ (50 mg, 200 mg, and 400 mg oral solution) and compared with corresponding values during a control session (in the absence of ITZ). In all sessions, MDZ was administered 4 h after the ITZ oral solution. The plasma concentration–time curves of MDZ are shown in <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/figure/F1/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1a</span></a>. <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/table/T1/" target="true" class="fig-table-link table figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a> summarizes the pharmacokinetic parameters of MDZ in the four study sessions. MDZ area under the plasma concentration–time curve (AUC)<sub>0–∞</sub> increased and oral clearance decreased significantly (<em>P</em> &lt; 0.01) with increasing ITZ doses (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/figure/F1/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1b</span></a> and <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/table/T1/" target="true" class="fig-table-link table figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). The MDZ AUC<sub>0–∞</sub> increased on average 2.0-, 4.7-, and 5.4-fold compared with control after the 50-, 200-, and 400-mg ITZ doses, respectively (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/table/T1/" target="true" class="fig-table-link table figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). The increase in MDZ AUC corresponded to a 50, 79, and 82% decrease in MDZ oral clearance after 50-, 200-, and 400-mg doses of ITZ, respectively. A significantly greater decrease (<em>P</em> &lt; 0.01) in the oral clearance of MDZ was observed after 200 and 400 mg ITZ than after 50 mg ITZ. The decrease in MDZ oral clearance was accompanied by a significant increase in MDZ elimination half-life (<em>t</em><sub>1/2</sub>) (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/table/T1/" target="true" class="fig-table-link table figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>), suggesting inhibition of systemic clearance of MDZ. The <em>t</em><sub>1/2</sub> increased 1.7-, 2.8-, and 3.2-fold from baseline after 50-, 200-, and 400-mg doses of ITZ, respectively.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a class="icnblk_img figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><img src="./PMC3056523_files/nihms-268021-f0001.gif" class="small-thumb" alt="Figure 1" title="Figure 1" src-large="/pmc/articles/PMC3056523/bin/nihms-268021-f0001.jpg"></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a4--><div><span>Effect of escalating doses of itraconazole (ITZ) on disposition of oral midazolam (MDZ). Panel <strong>a</strong> shows the plasma concentration–time curves for midazolam in the control session and three ITZ sessions. MDZ was administered 4 h after the oral dose</span> <strong>...</strong></div></div></div><!--table ft1--><!--table-wrap mode=article t1--><div class="table-wrap iconblock ten_col whole_rhythm clearfix" id="T1"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/table/T1/" target="table" rid-ob="ob-T1" rid-figpopup="T1" class="table img_link icnblk_img figpopup"><img alt="Table 1" title="Table 1" class="small-thumb" src="./PMC3056523_files/saved_resource" src-large="/pmc/articles/PMC3056523/table/T1/?report=previmg"></a><div class="icnblk_cntnt"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/table/T1/" target="table" rid-figpopup="T1" rid-ob="ob-T1">Table 1</a></div><!--caption a4--><div><span>Average pharmacokinetic parameters of MDZ determined after each session</span></div></div></div><p id="P6">The average plasma concentrations of ITZ, OH-ITZ, keto-ITZ, and ND-ITZ during MDZ elimination were determined from plasma concentration–time data (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/table/T2/" target="true" class="fig-table-link table figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). As expected, greater-than-dose-proportional increases in ITZ and OH-ITZ concentrations were observed, but keto-ITZ and ND-ITZ plasma concentrations increased less than dose proportionally, leading to a decrease in the ratio of metabolite to ITZ concentration with increasing doses of ITZ. The ratio of OH-ITZ to ITZ concentration remained constant even with increasing doses of ITZ.</p><!--table ft1--><!--table-wrap mode=article t1--><div class="table-wrap iconblock ten_col whole_rhythm clearfix" id="T2"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/table/T2/" target="table" rid-ob="ob-T2" rid-figpopup="T2" class="table img_link icnblk_img figpopup"><img alt="Table 2" title="Table 2" class="small-thumb" src="./PMC3056523_files/saved_resource(1)" src-large="/pmc/articles/PMC3056523/table/T2/?report=previmg"></a><div class="icnblk_cntnt"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/table/T2/" target="table" rid-figpopup="T2" rid-ob="ob-T2">Table 2</a></div><!--caption a4--><div><span>Average plasma concentrations (AUC/τ, τ = 19.5 h, the MDZ sampling interval) of ITZ and its metabolites during MDZ sampling period</span></div></div></div><p id="P7">The measurement of inhibitor concentrations in each individual permitted the determination of apparent <em>in vivo</em> IC<sub>50</sub> values for ITZ, with the assumption that the CYP3A inhibition is entirely attributable to ITZ. <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/figure/F2/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a> shows the relationship between ITZ concentration and inhibition of clearance of oral MDZ in each of the six subjects, with the individual apparent IC<sub>50</sub> values also indicated. The mean <em>in vivo</em> IC<sub>50</sub> for ITZ was 32 nmol/l, which is equivalent to an unbound IC<sub>50</sub> value of 1.2 nmol/l. Subject 6 was determined to be an outlier with respect to the <em>in vivo</em> IC<sub>50</sub> value (<em>P</em> &lt; 0.01). When this outlier in IC<sub>50</sub> values was excluded (<em>in vivo</em> IC<sub>50</sub> 132 nmol/l), the average <em>in vivo</em> IC<sub>50</sub> was 11.7 nmol/l and unbound IC<sub>50</sub> was 0.42 nmol/l. The maximum <em>in vivo</em> inhibition (<em>E</em><sub>max</sub>) was in the range of 82–88% in the six subjects studied (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/figure/F2/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>), corresponding to the reported <em>f</em><sub>m</sub> for MDZ by CYP3A4.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a class="icnblk_img figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><img src="./PMC3056523_files/nihms-268021-f0002.gif" class="small-thumb" alt="Figure 2" title="Figure 2" src-large="/pmc/articles/PMC3056523/bin/nihms-268021-f0002.jpg"></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a4--><div><span><em>In vivo</em> inhibitory potency (IC<sub>50</sub> values) for itraconazole (ITZ) in the six study subjects. The subjects are labeled “S” along with a study number, and the fitted IC<sub>50</sub> value is given in the inset of each panel. The maximum percent inhibition</span> <strong>...</strong></div></div></div><p id="P8">Because ITZ metabolites also exert an inhibitory effect, the relative contributions of the metabolites of ITZ to the decrease in the clearance of oral MDZ were predicted using the ratio of average unbound plasma concentrations to <em>in vitro</em> unbound IC<sub>50</sub> values, as reported by Isoherranen <em>et al</em>.<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946199" role="button" aria-expanded="false" aria-haspopup="true">3</a></sup> The observed unbound plasma [I]/<em>in vitro</em> IC<sub>50</sub> ratios for ITZ and its metabolites are shown in <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/table/T3/" target="true" class="fig-table-link table figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>. <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure S1</a> online depicts the predicted percentage contribution by each inhibitor to the overall observed CYP3A4 inhibition after the administration of escalating doses of ITZ. On average, ITZ was predicted to be responsible for 50–60% of the overall CYP3A4 inhibition, and this predicted contribution of ITZ did not change with increasing doses. On the basis of unbound values, the sum of the effects of the three metabolites was approximately equivalent to that of ITZ in CYP3A4 inhibition. Despite the low circulating concentrations of ND-ITZ, the [I]<sub>u</sub>/IC<sub>50,u</sub> ratios suggested that this metabolite contributes 10–20% to the total CYP3A4 inhibition.</p><!--table ft1--><!--table-wrap mode=article t1--><div class="table-wrap iconblock ten_col whole_rhythm clearfix" id="T3"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/table/T3/" target="table" rid-ob="ob-T3" rid-figpopup="T3" class="table img_link icnblk_img figpopup"><img alt="Table 3" title="Table 3" class="small-thumb" src="./PMC3056523_files/saved_resource(2)" src-large="/pmc/articles/PMC3056523/table/T3/?report=previmg"></a><div class="icnblk_cntnt"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/table/T3/" target="table" rid-figpopup="T3" rid-ob="ob-T3">Table 3</a></div><!--caption a4--><div><span>Relative inhibitory potency of ITZ and its metabolites as calculated using the [I]/IC<sub>50</sub> ratio of each compound after escalating doses of ITZ</span></div></div></div><p id="P9">The time course of CYP3A4 inhibition was also predicted using the [I]<sub>u</sub>/IC<sub>50,u</sub> values for ITZ alone and for ITZ with its metabolites throughout the ITZ administration period (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#SD2" rid="SD2" class=" supplementary-material">Supplementary Figure S2</a> online). The contribution of the metabolites increased with time, leading to a greater contribution of the metabolites to CYP3A4 inhibition 12–24 h after dosing. This resulted in a more persistent inhibition (up to 48 h) after the 400-mg ITZ dose than would be predicted from the effect of ITZ alone. In the case of a substrate with a long half-life, this persistent inhibitory effect of the metabolites may be more significant and contribute to greater underpredictions than with a probe such as MDZ, which has a relatively short half-life.</p><p id="P10">The impact of ITZ and its metabolites to the overall clearance of oral MDZ was predicted using unbound plasma concentrations in each subject and pharmacokinetic models of CYP3A4 inhibition in the gut and in the liver. The predicted inhibition of intestinal and hepatic CYP3A4 by ITZ and its metabolites after each ITZ dose is shown in <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/table/T4/" target="true" class="fig-table-link table figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>. The gut bioavailability (<em>F</em><sub>g</sub><sup>i</sup>/<em>F</em><sub>g</sub>) after the 50-, 200-, and 400-mg ITZ doses was predicted to increase to 1.1, 1.5, and 1.6 times the baseline value of <em>F</em><sub>g</sub> (55%), respectively, when the combined effects of ITZ and its metabolites were considered. The predicted maximum value of <em>F</em><sub>g</sub> after the highest ITZ dose was 87%. The predicted percentage decrease in the hepatic intrinsic clearance is shown in <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/table/T4/" target="true" class="fig-table-link table figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>. A maximum of 76% decrease in the systemic clearance of MDZ was predicted after the 400-mg dose of ITZ. Taking into consideration both gut and hepatic inhibition of CYP3A4, a maximum overall decrease of 85% in the clearance of oral MDZ was predicted (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/table/T4/" target="true" class="fig-table-link table figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>), which agrees well with the observed 82–88% maximum decrease (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/figure/F2/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>).</p><!--table ft1--><!--table-wrap mode=article t1--><div class="table-wrap iconblock ten_col whole_rhythm clearfix" id="T4"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/table/T4/" target="table" rid-ob="ob-T4" rid-figpopup="T4" class="table img_link icnblk_img figpopup"><img alt="Table 4" title="Table 4" class="small-thumb" src="./PMC3056523_files/saved_resource(3)" src-large="/pmc/articles/PMC3056523/table/T4/?report=previmg"></a><div class="icnblk_cntnt"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/table/T4/" target="table" rid-figpopup="T4" rid-ob="ob-T4">Table 4</a></div><!--caption a4--><div><span>Predicted gut availability (<em>F</em><sub>g</sub>) and average changes in systemic clearance (Cl<sub>systemic</sub>), and clearance (Cl/F) of oral midazolam calculated using Eqs. <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#FD2" rid="FD2" class=" disp-formula">2</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#FD4" rid="FD4" class=" disp-formula">4</a>, and 6, considering ITZ alone or both ITZ and its metabolites</span></div></div></div><p id="P11">On the basis of the plasma concentrations of ITZ and its metabolites in each subject, the overall increase in MDZ AUC was predicted for each study subject, using the static model described in <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#FD5" rid="FD5" class=" disp-formula">Equation 5</a>. This predicted overall increase was compared with the observed interactions after escalating ITZ doses. On average, the predicted increase in the AUCs of oral MDZ after 50-, 200-, and 400-mg doses of ITZ were 1.4 ± 0.2, 4.5 ± 0.6, and 6.8 ± 0.8 fold, respectively, when the effects of ITZ and its metabolites were considered, and 1.2 ± 0.1, 2.9 ± 0.5, and 4.7 ± 0.7, respectively, after each of the three doses when the effect of ITZ alone was considered. There was no significant difference between the observed and predicted AUCs after each ITZ dose (<em>P</em> = 0.07, 0.3, and 0.4 for the 50 -, 200-, and 400-mg ITZ doses, respectively). The comparison between predicted and observed interactions is shown in <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/figure/F3/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>. When the effect of ITZ alone was considered in the predictions, 78% of all the interactions were underpredicted, and three of these (26% of the total) individual interactions were underpredicted by more than twofold. When the effects of the ITZ metabolites were also taken into account, 50% of the interactions were underpredicted, with only one interaction being underpredicted by more than twofold. An overall improvement in the prediction accuracy was observed.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a class="icnblk_img figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><img src="./PMC3056523_files/nihms-268021-f0003.gif" class="small-thumb" alt="Figure 3" title="Figure 3" src-large="/pmc/articles/PMC3056523/bin/nihms-268021-f0003.jpg"></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a4--><div><span>Predicted vs. observed interactions between itraconazole (ITZ) and midazolam after escalating doses of ITZ. The circles represent data from each individual subject after a 50-mg dose of ITZ; the boxes represent the data from each subject after the 200-mg</span> <strong>...</strong></div></div></div><p id="P12" class="p p-last">In order to test whether prediction accuracy was affected by ITZ dose, the predicted interactions using ITZ data alone were compared with those of ITZ and its three metabolites after each dose level. With data related to ITZ alone, 40, 38, and 13% underpredictions in the magnitude of interactions were observed after 50-, 200-, and 400-mg doses, respectively, and the accuracy of prediction improved with increasing ITZ doses. When the data related to the metabolites were also accounted for in predictions, a 22% underprediction was observed after the 50-mg ITZ dose, an 8% overprediction after the 200-mg dose, and 40% overprediction after the 400-mg dose, on average. Although all these average predictions are within a twofold range of the observed interaction, a dose-dependent effect on prediction accuracy was observed, and, as would be expected given the nonlinear (capacity limited) formation of ITZ metabolites, prediction accuracy improved with increasing doses when data for ITZ alone were analyzed.</p></div><div id="S2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-11"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-12">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S2title">DISCUSSION</h2><p id="P13" class="p p-first">The objective of this study was to determine the relative importance of ITZ metabolites to CYP3A4 inhibition after the administration of escalating doses of ITZ. It also aimed to establish whether the magnitude of CYP3A4 inhibition after ITZ administration could be rationalized using <em>in vitro</em> values for CYP3A4 inhibition by ITZ and its metabolites and the measured plasma concentrations of all the potential inhibitors. The data presented show that accurate interaction predictions could be reached after each dose level and that the metabolites contribute to ~50% of the overall CYP3A4 inhibition.</p><p id="P14">Previous studies have determined variable magnitudes of inhibition of MDZ clearance by ITZ.<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304664341" role="button" aria-expanded="false" aria-haspopup="true">9</a></sup><sup>-</sup><sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946195" role="button" aria-expanded="false" aria-haspopup="true">11</a></sup> The 4.7-fold increase in MDZ AUC observed in this study after 200 mg ITZ is in good agreement with the previously observed 3.4-fold increase when MDZ was administered 2 h after a single 200-mg dose of ITZ and the 6.6-fold increase when MDZ was administered after 200 mg ITZ daily for 6 days.<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304664340" role="button" aria-expanded="false" aria-haspopup="true">9</a></sup> However, the maximum inhibition observed in this study (5.4-fold increase in MDZ AUC) after a 400-mg dose of ITZ is less than the maximum 10.8-fold increase observed in exposure (AUC<sub>0–∞</sub>) when oral MDZ was administered after four daily doses of 200 mg of ITZ, the latter being administered 1 h before MDZ.<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_304664339" role="button" aria-expanded="false" aria-haspopup="true">9</a></sup></p><p id="P15">The maximum extent of inhibition observed in this study was lower than would be expected on the basis of previous studies. This difference may be due to differences in the staggering of MDZ and ITZ doses. In previous studies, MDZ was administered 1 or 2 h after ITZ (at ITZ’s <em>t</em><sub>max</sub>), whereas in this study ITZ was given 4 h prior to MDZ administration so as to ensure complete ITZ absorption at the time of MDZ administration and to provide for more accurate testing of <em>in vitro</em> to <em>in vivo</em> extrapolation. It is expected that if MDZ is administered at the time point of <em>t</em><sub>max</sub> of ITZ, a greater effect on <em>F</em><sub>g</sub> and <em>F</em><sub>h</sub> will be observed than with a dose-staggered design. However, in a study that investigated the effect of ingestion time interval on the interaction between ITZ and triazolam, a larger magnitude of inhibition was observed when ITZ and triazolam doses were separated by 3 or 12 h as compared with administering them simultaneously,<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946213" role="button" aria-expanded="false" aria-haspopup="true">12</a></sup> thereby suggesting that ITZ causes a persistent inhibition of CYP3A4, perhaps because of its circulating metabolites. Unfortunately, in these studies involving dose staggering and timing of administration, the concentrations of the circulating metabolites were not available, and therefore the relative contributions of the metabolites cannot be characterized.</p><p id="P16">Persistent inhibition of CYP3A4-mediated MDZ clearance after four doses of ITZ (200 mg daily) has been previously reported.<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946205" role="button" aria-expanded="false" aria-haspopup="true">13</a></sup> Four days after cessation of ITZ dosing, a 2.6-fold increase in MDZ AUC was still observed relative to the control. An evaluation of the time course of inhibition by all circulating inhibitors in this study indicates that the persistent inhibition of CYP3A4 after ITZ dosing is due, at least in part, to the effects of inhibitory metabolites with long half-lives. The concentrations and relative exposures to ITZ and its metabolites observed in this study were in excellent agreement with those observed previously, and the predicted time course of inhibition agrees with that predicted previously.<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_286160542" role="button" aria-expanded="false" aria-haspopup="true">8</a></sup> After single doses of ITZ, the exposure to OH-ITZ was, on average, twofold greater than the exposure to ITZ, whereas keto-ITZ and ND-ITZ exposures were ~10% of the ITZ exposure. Extrapolation of these exposures of ITZ metabolites to multiple dosing situations will require additional mechanistic <em>in vitro</em> studies of the sequential metabolism of ITZ and the elimination pathways of the metabolites. In addition, complex models will be required to simulate the time- and dose-dependent disposition of ITZ and its metabolites.</p><p id="P17">On the basis of data related to plasma concentrations of ITZ and predictions of <em>F</em><sub>g</sub>, it can be inferred from this study that gut metabolism of MDZ was not completely inhibited, even after the 400-mg dose of ITZ. Assuming that circulating plasma concentrations are indicative of inhibitor concentration in the gut wall 4 h after ITZ administration, only a small change (6% increase) in gut availability of MDZ is predicted after the 50-mg ITZ dose; after the 400-mg dose of ITZ, the gut availability of MDZ was predicted to increase to 87% (1.6-fold increase) suggesting that with increase in ITZ doses further inhibition of gut CYP3A4 would be possible. Indeed, the plateau maximum inhibition predicted from the <em>in vivo</em> IC<sub>50</sub> fits was a 7.7-fold increase in MDZ AUC as compared with the observed 5.4-fold increase after the 400-mg dose.</p><p id="P18">The literature indicates the existence of a relationship between inhibitor dose and observed magnitude of interaction.<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946189" role="button" aria-expanded="false" aria-haspopup="true">14</a></sup> However, rarely is a plateau of inhibition clearly demonstrated in such studies, and <em>in vivo</em> IC<sub>50</sub> values are usually not calculated. An inhibition plateau with increasing ITZ doses has previously been observed with triazolam when triazolam was administered 3 h after a 200- or 400-mg oral dose of ITZ. Only a marginal (1.1-fold) increase in the inhibition was observed between the two doses.<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946192" role="button" aria-expanded="false" aria-haspopup="true">12</a></sup> The fact that a plateau is observed is most likely a result of the fact that ITZ inhibits only CYP3A and no alternative elimination pathways of MDZ or triazolam.</p><p id="P19">The use of <em>in vivo K</em><sub>i</sub> has been proposed as a method for comparing an inhibitor’s potency <em>in vitro</em> and <em>in vivo</em>.<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946203" role="button" aria-expanded="false" aria-haspopup="true">15</a></sup> A ratio greater than 1 between the <em>in vitro</em> and <em>in vivo K</em><sub>i</sub> (RK<sub>i</sub>) suggests that factors such as inhibitory metabolites and uptake transport may contribute to <em>in vivo</em> interaction, making the inhibitor more potent <em>in vivo</em> than <em>in vitro</em>. The same principle can be applied to IC<sub>50</sub> values for reversible inhibitors such as ITZ. An apparent <em>in vivo</em> IC<sub>50</sub> for ITZ in all six study subjects was determined, and the ratio between the <em>in vitro</em> and <em>in vivo</em> unbound IC<sub>50</sub> values for ITZ was 5.1 (including data from all subjects) or 14.5 (with data from one outlier excluded), suggesting that ITZ is a more potent inhibitor <em>in vivo</em> than <em>in vitro</em>. One plausible explanation for this difference is that the metabolites of ITZ contribute to the observed <em>in vivo</em> CYP3A4 inhibition, although the possibility of active hepatocellular uptake of ITZ as a factor cannot be excluded.</p><p id="P20">A comparison of the [I]/IC<sub>50</sub> ratios for ITZ and its metabolites supports the hypothesis that the metabolites have a distinct role in CYP3A4 inhibition. On average, the predictions based on ITZ alone underpredicted the observed change in MDZ AUC, although most static predictions were within a twofold margin of error. The static prediction was improved when the inhibitory contribution of the metabolites was accounted for, again suggesting that metabolites are quantitatively important in CYP3A4 inhibition caused by ITZ. The contribution of metabolites to perceived risks of DDIs was also important. When ITZ alone was considered after the 400-mg dose of ITZ, it was predicted to result in moderate CYP3A4 interactions. However, when metabolites were included in the predictions, ITZ was predicted to be a potent inhibitor.</p><p id="P21">The average magnitude of interaction between ITZ and MDZ after the three different ITZ doses could be accurately predicted despite the large interindividual variability in the magnitude of interaction. Even when the concentrations of all four circulating inhibitors were known and used in the prediction of the interaction in the same individual, the prediction accuracy in some individuals was outside the twofold range. This suggests that factors other than the absolute exposure to the inhibitor contribute to an individual’s sensitivity to DDIs. For example, variability in the individual <em>f</em><sub>m</sub> for CYP3A4, determined partially by the expression levels of other enzymes contributing to MDZ clearance (UDP-glucuronosyltransferases), may be responsible for this interindividual variability.</p><p id="P22" class="p p-last">In conclusion, this study was conducted to determine whether the metabolites of ITZ play a quantitatively important role in <em>in vivo</em> CYP3A4 inhibition. All the results obtained support the fact that approximately half of the CYP3A4 inhibition observed <em>in vivo</em> after ITZ dosing is caused by circulating metabolites of ITZ. The fivefold difference between the <em>in vitro</em> and <em>in vivo</em> IC<sub>50</sub> values for ITZ may be rationalized by accounting for the inhibitory metabolites. When metabolites were accounted for, accurate predictions of the <em>in vivo</em> interaction were obtained after all three escalating doses of ITZ. These results demonstrate the usefulness of the <em>in vivo</em> IC<sub>50</sub> (or <em>K</em><sub>i</sub>) in determining additional factors that contribute to <em>in vivo</em> interactions and the importance of accounting for inhibitory metabolites when quantitative predictions of interactions are conducted.</p></div><div id="S3" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-13"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-14">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S3title">METHODS</h2><div id="S4" class="sec sec-first"><h3>Clinical protocol</h3><p id="P23" class="p p-first">The University of Washington Institutional Review Board approved this protocol. Six healthy volunteers, one woman and five men in the age range of 22–42 (mean 34) years and within 20% of optimal body mass index, participated in the study after giving their written informed consent. None of the subjects had a history of systemic disease. A standard clinical renal and hepatic function panel of laboratory test values was obtained from each subject, and all values were within the normal ranges. Tobacco smoking and a history of allergy to antifungal drugs were also part of the exclusion criteria. Each subject was genotyped for CYP3A5, and only subjects homozygous for CYP3A5*3 were enrolled. In brief, a buccal cell sample from each subject was collected using Cyto-pak cytosoft brushes (Medical Packing, Camarillo, CA), and genomic DNA was extracted using a QIAamp DNA Mini Kit (Qiagen Science, Germantown, MD) in accordance with the manufacturer’s instructions. The <em>CYP3A5*3</em> status of the subjects was determined using Stepone Plus real-time PCR and TaqMan genotyping assay (assay ID C26201809_30) in accordance with the manufacturer’s recommendations (Applied Biosystems, Foster City, CA).</p><p id="P24" class="p p-last">Subjects were asked to abstain from over-the-counter and prescription medications from 1 week before the administration of study medications to 3 weeks after the completion of the study. They were also asked to abstain from eating grapefruit and grapefruit products for the duration of the study and to avoid alcohol and caffeine from 1 day before through the end of each urine-collection period. The study was divided into four sessions: a control session to measure baseline oral MDZ elimination, followed by three successive sessions with escalating doses (50, 200, and 400 mg) of ITZ. Each session was separated from the subsequent one by a washout period of at least 2 weeks. In each session, the subjects received 2 mg MDZ in oral solution. In the sessions involving ITZ dosing, the MDZ was administered 4 h after ITZ. A standard lunch was served 30 min after the MDZ dose. For the determination of MDZ concentrations, blood samples were collected through indwelling venous catheters into EDTA-containing tubes (BD Vacutainer; BD Biosciences, Franklin Lakes, NJ) before MDZ administration and at 0.5, 1, 2, 3, 4, 6, 8, and 12 h after administration (during the control session, no samples were collected at the 12-h time point). An additional blood sample was drawn by venous puncture 20 h after MDZ administration. Plasma was isolated from blood by centrifugation and stored at −20 °C before analysis.</p></div><div id="S5" class="sec"><h3>Measurements of plasma concentrations of MDZ and ITZ</h3><p id="P25" class="p p-first">Concentrations of MDZ and ITZ in the plasma samples were measured using high-performance liquid chromatography with mass-spectrometry detection as described previously<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_286160544" role="button" aria-expanded="false" aria-haspopup="true">8</a></sup> except that a Waters Micromass (Manchester, UK) LC–MS platform mass spectrometer was used to analyze the samples. A calibration curve for MDZ was prepared using pooled blank human plasma separated from whole blood acquired from the Northwest Blood Bank. Calibration standards were prepared at concentrations between 1 and 150 nmol/l (from 100 μl plasma). The limit of quantification for MDZ was 1 nmol/l. Quality-control samples containing 3, 31, and 77 nmol/l MDZ were included with each analysis. The interday variability for MDZ was &lt;3% at 77 nmol/l, &lt;2% at 31 nmol/l, and &lt;14% at 3 nmol/l.</p><p id="P26" class="p p-last">Calibration curves for ITZ, OH-ITZ, keto-ITZ, and ND-ITZ were also prepared in pooled blank human plasma prepared from Northwest Blood Bank whole blood. Calibration standards were prepared at concentrations ranging from 4 to 1,500 nmol/l (from 0.1 ml plasma). The limit of detection for ITZ and metabolites was 1 nmol/l, and the limit of quantification was 5 nmol/l. Quality-control samples containing ITZ and metabolites at 50, 500, and 1,000 nmol/l were included with each analysis. The interday variability for ITZ and its metabolites was &lt;10% at 1,000 nmol/l, &lt;10% at 500 nmol/l, and &lt;20% at 50 nmol/l.</p></div><div id="S6" class="sec"><h3>Pharmacokinetic calculations</h3><p id="P27" class="p p-first-last">The AUC after each oral MDZ dose was calculated using the trapezoidal method (WinNonlin; Pharsight, Mountain View, CA). The MDZ dose was divided by the value of AUC<sub>0–∞</sub> to calculate the clearance of oral MDZ. Elimination half-life was obtained from the linear terminal slope of the MDZ plasma concentration–time curve. The AUCs of ITZ, OH-ITZ, keto-ITZ, and ND-ITZ were calculated from 4.5 to 24 h after ITZ administration, to correspond to the interval of MDZ exposure. The AUC of the inhibitor was divided by this time interval (19.5 h) to calculate average inhibitor concentration (<em>C</em><sub>ave</sub>) during MDZ administration. The increase in MDZ AUC after each ITZ dose was calculated as the ratio of inhibited AUC to control-session AUC.</p></div><div id="S7" class="sec"><h3>Determination of <em>in vivo</em> IC<sub>50</sub></h3><div id="P28"><p>The <em>in vivo</em> IC<sub>50</sub> for ITZ was calculated using GraphPad Prism (GraphPad Software, La Jolla, CA). The ratio of clearance of oral MDZ under inhibited conditions (CL<sub>I</sub>) and control conditions (CL) was calculated for each of the subjects for all four sessions. IC<sub>50</sub> and maximum inhibition (<em>E</em><sub>max</sub>) were then obtained by fitting the dose–response (inhibition) model to the data according to <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#FD1" rid="FD1" class=" disp-formula">Equation 1</a>, in which CL<sub>I</sub>/CL is modeled as a function of the total ITZ <em>C</em><sub>ave</sub>.
</p><div class="disp-formula" id="FD1"><div class="f"><span class="MathJax_Preview"></span><div class="MathJax_Display" style="text-align: center;"><span class="MathJax" id="MathJax-Element-1-Frame" tabindex="0"><nobr><span class="math" id="M1" overflow="scroll" role="math" style="width: 28.682em; display: inline-block;"><span style="display: inline-block; position: relative; width: 23.138em; height: 0px; font-size: 124%;"><span style="position: absolute; clip: rect(1.363em 1023.14em 8.067em -999.997em); top: -6.096em; left: 0.003em;"><span class="mrow" id="MathJax-Span-2"><span class="mrow" id="MathJax-Span-3"><span class="msub" id="MathJax-Span-4"><span style="display: inline-block; position: relative; width: 1.716em; height: 0px;"><span style="position: absolute; clip: rect(3.178em 1001.26em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-5" style="font-family: STIXGeneral-Regular;">CL</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 1.263em;"><span class="mn" id="MathJax-Span-6" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">1</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mo" id="MathJax-Span-7" style="font-size: 337.5%; font-family: STIXGeneral-Regular; padding-left: 0.204em;">/</span><span class="mi" id="MathJax-Span-8" style="font-family: STIXGeneral-Regular;">CL</span><span class="mo" id="MathJax-Span-9" style="font-family: STIXGeneral-Regular; padding-left: 0.305em;">=</span><span class="msub" id="MathJax-Span-10" style="padding-left: 0.305em;"><span style="display: inline-block; position: relative; width: 6.908em; height: 0px;"><span style="position: absolute; clip: rect(2.623em 1005.65em 6.958em -999.997em); top: -5.038em; left: 0.003em;"><span class="mrow" id="MathJax-Span-11"><span class="mo" id="MathJax-Span-12" style="vertical-align: 2.271em;"><span style="display: inline-block; position: relative; width: 0.456em; height: 0px;"><span style="position: absolute; font-family: STIXSizeOneSym; top: -3.274em; left: 0.003em;">⎛<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; font-family: STIXSizeOneSym; top: -0.199em; left: 0.003em;">⎝<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -2.518em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -1.762em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -1.006em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mrow" id="MathJax-Span-13"><span class="msub" id="MathJax-Span-14"><span style="display: inline-block; position: relative; width: 1.716em; height: 0px;"><span style="position: absolute; clip: rect(3.178em 1001.26em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-15" style="font-family: STIXGeneral-Regular;">CL</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 1.263em;"><span class="mn" id="MathJax-Span-16" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">1</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mo" id="MathJax-Span-17" style="font-size: 337.5%; font-family: STIXGeneral-Regular; padding-left: 0.204em;">/</span><span class="mi" id="MathJax-Span-18" style="font-family: STIXGeneral-Regular; padding-left: 0.204em;">CL</span></span><span class="mo" id="MathJax-Span-19" style="vertical-align: 2.271em;"><span style="display: inline-block; position: relative; width: 0.456em; height: 0px;"><span style="position: absolute; font-family: STIXSizeOneSym; top: -3.274em; left: 0.003em;">⎞<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; font-family: STIXSizeOneSym; top: -0.199em; left: 0.003em;">⎠<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -2.518em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -1.762em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -1.006em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 5.043em;"></span></span><span style="position: absolute; top: -2.165em; left: 5.698em;"><span class="mi" id="MathJax-Span-20" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">min</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mo" id="MathJax-Span-21" style="font-family: STIXGeneral-Regular; padding-left: 0.255em;">+</span><span class="mfrac" id="MathJax-Span-22" style="padding-left: 0.255em;"><span style="display: inline-block; position: relative; width: 8.924em; height: 0px; margin-right: 0.103em; margin-left: 0.103em;"><span style="position: absolute; clip: rect(2.674em 1008.57em 7.059em -999.997em); top: -7.356em; left: 50%; margin-left: -4.282em;"><span class="mrow" id="MathJax-Span-23"><span class="mn" id="MathJax-Span-24" style="font-family: STIXGeneral-Regular;">1</span><span class="mo" id="MathJax-Span-25" style="font-family: STIXGeneral-Regular; padding-left: 0.255em;">−</span><span class="msub" id="MathJax-Span-26" style="padding-left: 0.255em;"><span style="display: inline-block; position: relative; width: 6.908em; height: 0px;"><span style="position: absolute; clip: rect(2.623em 1005.65em 6.958em -999.997em); top: -5.038em; left: 0.003em;"><span class="mrow" id="MathJax-Span-27"><span class="mo" id="MathJax-Span-28" style="vertical-align: 2.271em;"><span style="display: inline-block; position: relative; width: 0.456em; height: 0px;"><span style="position: absolute; font-family: STIXSizeOneSym; top: -3.274em; left: 0.003em;">⎛<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; font-family: STIXSizeOneSym; top: -0.199em; left: 0.003em;">⎝<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -2.518em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -1.762em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -1.006em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mrow" id="MathJax-Span-29"><span class="msub" id="MathJax-Span-30"><span style="display: inline-block; position: relative; width: 1.716em; height: 0px;"><span style="position: absolute; clip: rect(3.178em 1001.26em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-31" style="font-family: STIXGeneral-Regular;">CL</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 1.263em;"><span class="mn" id="MathJax-Span-32" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">1</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mo" id="MathJax-Span-33" style="font-size: 337.5%; font-family: STIXGeneral-Regular; padding-left: 0.204em;">/</span><span class="mi" id="MathJax-Span-34" style="font-family: STIXGeneral-Regular; padding-left: 0.204em;">CL</span></span><span class="mo" id="MathJax-Span-35" style="vertical-align: 2.271em;"><span style="display: inline-block; position: relative; width: 0.456em; height: 0px;"><span style="position: absolute; font-family: STIXSizeOneSym; top: -3.274em; left: 0.003em;">⎞<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; font-family: STIXSizeOneSym; top: -0.199em; left: 0.003em;">⎠<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -2.518em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -1.762em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -1.006em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 5.043em;"></span></span><span style="position: absolute; top: -2.165em; left: 5.698em;"><span class="mi" id="MathJax-Span-36" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">min</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 5.093em;"></span></span><span style="position: absolute; clip: rect(2.926em 1008.77em 4.186em -999.997em); top: -3.122em; left: 50%; margin-left: -4.383em;"><span class="mrow" id="MathJax-Span-37"><span class="mn" id="MathJax-Span-38" style="font-family: STIXGeneral-Regular;">1</span><span class="mo" id="MathJax-Span-39" style="font-family: STIXGeneral-Regular; padding-left: 0.255em;">+</span><span class="msup" id="MathJax-Span-40" style="padding-left: 0.255em;"><span style="display: inline-block; position: relative; width: 7.109em; height: 0px;"><span style="position: absolute; clip: rect(3.178em 1000.96em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mn" id="MathJax-Span-41" style="font-family: STIXGeneral-Regular;">10</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -4.383em; left: 1.011em;"><span class="mrow" id="MathJax-Span-42"><span class="mo" id="MathJax-Span-43" style="vertical-align: 0.003em;"><span><span style="font-size: 70.7%; font-family: STIXGeneral-Regular;">(</span></span></span><span class="mi" id="MathJax-Span-44" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">log</span><span class="mspace" id="MathJax-Span-45" style="height: 0.003em; vertical-align: 0.003em; width: 0.204em; display: inline-block; overflow: hidden;"></span><span class="msub" id="MathJax-Span-46" style="padding-left: 0.204em;"><span style="display: inline-block; position: relative; width: 1.212em; height: 0px;"><span style="position: absolute; clip: rect(3.38em 1000.51em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-47" style="font-size: 70.7%; font-family: STIXGeneral-Italic;">C<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.003em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.879em; left: 0.456em;"><span class="mi" id="MathJax-Span-48" style="font-size: 50%; font-family: STIXGeneral-Regular;">ave</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mo" id="MathJax-Span-49" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">−</span><span class="mi" id="MathJax-Span-50" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">log</span><span class="mspace" id="MathJax-Span-51" style="height: 0.003em; vertical-align: 0.003em; width: 0.204em; display: inline-block; overflow: hidden;"></span><span class="msub" id="MathJax-Span-52" style="padding-left: 0.204em;"><span style="display: inline-block; position: relative; width: 1.263em; height: 0px;"><span style="position: absolute; clip: rect(3.38em 1000.71em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-53" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">IC</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.879em; left: 0.708em;"><span class="mn" id="MathJax-Span-54" style="font-size: 50%; font-family: STIXGeneral-Regular;">50</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mo" id="MathJax-Span-55" style="vertical-align: 0.003em;"><span><span style="font-size: 70.7%; font-family: STIXGeneral-Regular;">)</span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(0.859em 1008.92em 1.212em -999.997em); top: -1.258em; left: 0.003em;"><span style="display: inline-block; overflow: hidden; vertical-align: 0.003em; border-top-width: 1.3px; border-top-style: solid; width: 8.924em; height: 0px;"></span><span style="display: inline-block; width: 0px; height: 1.061em;"></span></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 6.101em;"></span></span></span><span style="display: inline-block; overflow: hidden; vertical-align: -2.309em; border-left-width: 0px; border-left-style: solid; width: 0px; height: 8.066em;"></span></span></nobr></span></div><script type="math/mml" id="MathJax-Element-1"><math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="block" id="M1" overflow="scroll"><mrow><msub><mi>CL</mi><mn>1</mn></msub><mo mathsize="3em">/</mo><mi>CL</mi><mo>=</mo><msub><mrow><mo stretchy="true">(</mo><mrow><msub><mi>CL</mi><mn>1</mn></msub><mo mathsize="3em">/</mo><mi>CL</mi></mrow><mo stretchy="true">)</mo></mrow><mi>min</mi></msub><mo>+</mo><mfrac><mrow><mn>1</mn><mo>−</mo><msub><mrow><mo stretchy="true">(</mo><mrow><msub><mi>CL</mi><mn>1</mn></msub><mo mathsize="3em">/</mo><mi>CL</mi></mrow><mo stretchy="true">)</mo></mrow><mi>min</mi></msub></mrow><mrow><mn>1</mn><mo>+</mo><msup><mn>10</mn><mrow><mo>(</mo><mi>log</mi><mspace width="thinmathspace"></mspace><msub><mi>C</mi><mi>ave</mi></msub><mo>−</mo><mi>log</mi><mspace width="thinmathspace"></mspace><msub><mi>IC</mi><mn>50</mn></msub><mo>)</mo></mrow></msup></mrow></mfrac></mrow></math></script></div><div class="l">(1)</div></div><p>
(CL<sub>I</sub>/CL)<sub>min</sub> refers to the fitted minimum value for the clearance ratio, i.e., the maximum inhibition obtained.</p></div></div><div id="S8" class="sec"><h3>Statistical analysis</h3><p id="P29" class="p p-first-last">Data are expressed as mean values ± SD. Statistical analysis was preformed using Excel (Microsoft Office 2007; Microsoft, Redmond, WA). A paired <em>t</em>-test was used to evaluate the significance of the average change in MDZ AUC between the four study sessions. The same test was used to test the significance of the difference between predicted and observed changes in MDZ AUC after each ITZ dose. The presence of outliers in the <em>in vivo</em> IC<sub>50</sub> data was tested for, using the Grubbs’ test for outliers in GraphPad Prism. A two-tailed <em>P</em> value of &lt;0.0167 was considered significant after a Bonferroni correction to adjust the P value of &lt;0.05 for multiple comparisons.</p></div><div id="S9" class="sec sec-last"><h3><em>In vitro</em>–<em>in vivo</em> predictions</h3><div id="P30"><p>The effect of ITZ and its metabolites on the CYP3A4-mediated intrinsic clearance of MDZ was predicted using the relationship:
</p><div class="disp-formula" id="FD2"><div class="f"><span class="MathJax_Preview"></span><div class="MathJax_Display" style="text-align: center;"><span class="MathJax" id="MathJax-Element-2-Frame" tabindex="0"><nobr><span class="math" id="M2" overflow="scroll" role="math" style="width: 7.966em; display: inline-block;"><span style="display: inline-block; position: relative; width: 6.404em; height: 0px; font-size: 124%;"><span style="position: absolute; clip: rect(1.011em 1006.4em 3.531em -999.997em); top: -2.518em; left: 0.003em;"><span class="mrow" id="MathJax-Span-57"><span class="mrow" id="MathJax-Span-58"><span class="mfrac" id="MathJax-Span-59"><span style="display: inline-block; position: relative; width: 1.867em; height: 0px; margin-right: 0.103em; margin-left: 0.103em;"><span style="position: absolute; clip: rect(3.128em 1001.77em 4.287em -999.997em); top: -4.635em; left: 50%; margin-left: -0.905em;"><span class="mrow" id="MathJax-Span-60"><span class="msub" id="MathJax-Span-61"><span style="display: inline-block; position: relative; width: 1.767em; height: 0px;"><span style="position: absolute; clip: rect(3.128em 1000.91em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-62" style="font-family: STIXGeneral-Regular;">Cl</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 0.96em;"><span class="mi" id="MathJax-Span-63" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">int</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(3.128em 1000.91em 4.136em -999.997em); top: -3.274em; left: 50%; margin-left: -0.451em;"><span class="mi" id="MathJax-Span-64" style="font-family: STIXGeneral-Regular;">Cl</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(0.859em 1001.87em 1.212em -999.997em); top: -1.258em; left: 0.003em;"><span style="display: inline-block; overflow: hidden; vertical-align: 0.003em; border-top-width: 1.3px; border-top-style: solid; width: 1.867em; height: 0px;"></span><span style="display: inline-block; width: 0px; height: 1.061em;"></span></span></span></span><span class="mo" id="MathJax-Span-65" style="font-family: STIXGeneral-Regular; padding-left: 0.305em;">=</span><span class="mn" id="MathJax-Span-66" style="font-family: STIXGeneral-Regular; padding-left: 0.305em;">1</span><span class="mo" id="MathJax-Span-67" style="font-family: STIXGeneral-Regular; padding-left: 0.255em;">+</span><span class="mfrac" id="MathJax-Span-68" style="padding-left: 0.255em;"><span style="display: inline-block; position: relative; width: 1.111em; height: 0px; margin-right: 0.103em; margin-left: 0.103em;"><span style="position: absolute; clip: rect(3.178em 1000.91em 4.287em -999.997em); top: -4.635em; left: 50%; margin-left: -0.502em;"><span class="mrow" id="MathJax-Span-69"><span class="mo" id="MathJax-Span-70" style="font-family: STIXGeneral-Regular;">[</span><span class="mi" id="MathJax-Span-71" style="font-family: STIXGeneral-Regular;">I</span><span class="mo" id="MathJax-Span-72" style="font-family: STIXGeneral-Regular;">]</span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(3.178em 1001.01em 4.287em -999.997em); top: -3.274em; left: 50%; margin-left: -0.502em;"><span class="mrow" id="MathJax-Span-73"><span class="msub" id="MathJax-Span-74"><span style="display: inline-block; position: relative; width: 1.011em; height: 0px;"><span style="position: absolute; clip: rect(3.178em 1000.71em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-75" style="font-family: STIXGeneral-Regular;">K<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.003em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 0.708em;"><span class="mi" id="MathJax-Span-76" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">i</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(0.859em 1001.11em 1.212em -999.997em); top: -1.258em; left: 0.003em;"><span style="display: inline-block; overflow: hidden; vertical-align: 0.003em; border-top-width: 1.3px; border-top-style: solid; width: 1.111em; height: 0px;"></span><span style="display: inline-block; width: 0px; height: 1.061em;"></span></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.523em;"></span></span></span><span style="display: inline-block; overflow: hidden; vertical-align: -1.122em; border-left-width: 0px; border-left-style: solid; width: 0px; height: 2.878em;"></span></span></nobr></span></div><script type="math/mml" id="MathJax-Element-2"><math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="block" id="M2" overflow="scroll"><mrow><mfrac><mrow><msub><mi>Cl</mi><mi>int</mi></msub></mrow><mi>Cl</mi></mfrac><mo>=</mo><mn>1</mn><mo>+</mo><mfrac><mrow><mo>[</mo><mi mathvariant="normal">I</mi><mo>]</mo></mrow><mrow><msub><mi mathvariant="normal">K</mi><mi mathvariant="normal">i</mi></msub></mrow></mfrac></mrow></math></script></div><div class="l">(2)</div></div><p>
in which the value of IC<sub>50</sub> reported by Isoherranen <em>et al</em>.<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946202" role="button" aria-expanded="false" aria-haspopup="true">3</a></sup> was used for <em>K</em><sub>i</sub>. Because ITZ and its metabolites are competitive inhibitors, and the IC<sub>50</sub> values used were determined at [S]&lt;&lt;<em>K</em><sub>m</sub>, these IC<sub>50</sub> values are equal to the <em>K</em><sub>i</sub> values.<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946211" role="button" aria-expanded="false" aria-haspopup="true">3</a></sup> The general equation (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#FD3" rid="FD3" class=" disp-formula">Equation 3</a>)
</p><div class="disp-formula" id="FD3"><div class="f"><span class="MathJax_Preview"></span><div class="MathJax_Display" style="text-align: center;"><span class="MathJax" id="MathJax-Element-3-Frame" tabindex="0"><nobr><span class="math" id="M3" overflow="scroll" role="math" style="width: 22.23em; display: inline-block;"><span style="display: inline-block; position: relative; width: 17.896em; height: 0px; font-size: 124%;"><span style="position: absolute; clip: rect(1.968em 1017.85em 10.436em -999.997em); top: -6.449em; left: 0.003em;"><span class="mrow" id="MathJax-Span-78"><span class="mrow" id="MathJax-Span-79"><span class="mfrac" id="MathJax-Span-80"><span style="display: inline-block; position: relative; width: 2.523em; height: 0px; margin-right: 0.103em; margin-left: 0.103em;"><span style="position: absolute; clip: rect(3.178em 1002.37em 4.287em -999.997em); top: -4.635em; left: 50%; margin-left: -1.207em;"><span class="mrow" id="MathJax-Span-81"><span class="msub" id="MathJax-Span-82"><span style="display: inline-block; position: relative; width: 2.371em; height: 0px;"><span style="position: absolute; clip: rect(3.178em 1002.07em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-83" style="font-family: STIXGeneral-Regular;">AUC</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 2.119em;"><span class="mi" id="MathJax-Span-84" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">i</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(3.178em 1002.07em 4.136em -999.997em); top: -3.274em; left: 50%; margin-left: -1.056em;"><span class="mi" id="MathJax-Span-85" style="font-family: STIXGeneral-Regular;">AUC</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(0.859em 1002.52em 1.212em -999.997em); top: -1.258em; left: 0.003em;"><span style="display: inline-block; overflow: hidden; vertical-align: 0.003em; border-top-width: 1.3px; border-top-style: solid; width: 2.523em; height: 0px;"></span><span style="display: inline-block; width: 0px; height: 1.061em;"></span></span></span></span><span class="mo" id="MathJax-Span-86" style="font-family: STIXGeneral-Regular; padding-left: 0.305em;">=</span><span class="mrow" id="MathJax-Span-87" style="padding-left: 0.305em;"><span class="mo" id="MathJax-Span-88" style="vertical-align: -0.602em;"><span style="font-family: STIXSizeThreeSym;">(</span></span><span class="mfrac" id="MathJax-Span-89"><span style="display: inline-block; position: relative; width: 1.515em; height: 0px; margin-right: 0.103em; margin-left: 0.103em;"><span style="position: absolute; clip: rect(3.178em 1001.41em 4.438em -999.997em); top: -4.735em; left: 50%; margin-left: -0.703em;"><span class="mrow" id="MathJax-Span-90"><span class="msub" id="MathJax-Span-91"><span style="display: inline-block; position: relative; width: 1.414em; height: 0px;"><span style="position: absolute; clip: rect(3.178em 1000.66em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-92" style="font-family: STIXGeneral-Italic;">F<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.053em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 0.607em;"><span class="mrow" id="MathJax-Span-93"><span class="mi" id="MathJax-Span-94" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">g</span><span class="mo" id="MathJax-Span-95" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">,</span><span class="mi" id="MathJax-Span-96" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">i</span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(3.178em 1001.06em 4.438em -999.997em); top: -3.274em; left: 50%; margin-left: -0.502em;"><span class="mrow" id="MathJax-Span-97"><span class="msub" id="MathJax-Span-98"><span style="display: inline-block; position: relative; width: 1.061em; height: 0px;"><span style="position: absolute; clip: rect(3.178em 1000.66em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-99" style="font-family: STIXGeneral-Italic;">F<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.053em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 0.607em;"><span class="mi" id="MathJax-Span-100" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">g</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(0.859em 1001.51em 1.212em -999.997em); top: -1.258em; left: 0.003em;"><span style="display: inline-block; overflow: hidden; vertical-align: 0.003em; border-top-width: 1.3px; border-top-style: solid; width: 1.515em; height: 0px;"></span><span style="display: inline-block; width: 0px; height: 1.061em;"></span></span></span></span><span class="mo" id="MathJax-Span-101" style="vertical-align: -0.602em;"><span style="font-family: STIXSizeThreeSym;">)</span></span></span><span class="mo" id="MathJax-Span-102" style="font-family: STIXGeneral-Regular; padding-left: 0.255em;">⋅</span><span class="mrow" id="MathJax-Span-103" style="padding-left: 0.255em;"><span class="mo" id="MathJax-Span-104" style="vertical-align: 4.337em;"><span style="display: inline-block; position: relative; width: 0.456em; height: 0px;"><span style="position: absolute; font-family: STIXSizeOneSym; top: -3.274em; left: 0.003em;">⎛<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; font-family: STIXSizeOneSym; top: 3.934em; left: 0.003em;">⎝<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -2.366em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -1.459em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -0.552em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 0.305em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 1.212em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 2.119em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 3.027em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mfrac" id="MathJax-Span-105"><span style="display: inline-block; position: relative; width: 8.722em; height: 0px; margin-right: 0.103em; margin-left: 0.103em;"><span style="position: absolute; clip: rect(3.178em 1000.41em 4.136em -999.997em); top: -4.635em; left: 50%; margin-left: -0.249em;"><span class="mn" id="MathJax-Span-106" style="font-family: STIXGeneral-Regular;">1</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(2.523em 1008.62em 6.757em -999.997em); top: -2.719em; left: 50%; margin-left: -4.282em;"><span class="mrow" id="MathJax-Span-107"><span class="mo" id="MathJax-Span-108" style="vertical-align: 2.22em;"><span style="display: inline-block; position: relative; width: 0.456em; height: 0px;"><span style="position: absolute; font-family: STIXSizeOneSym; top: -3.274em; left: 0.003em;">⎛<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; font-family: STIXSizeOneSym; top: -0.401em; left: 0.003em;">⎝<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -2.316em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -1.358em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mn" id="MathJax-Span-109" style="font-family: STIXGeneral-Regular;">1</span><span class="mo" id="MathJax-Span-110" style="font-family: STIXGeneral-Regular; padding-left: 0.255em;">−</span><span class="msub" id="MathJax-Span-111" style="padding-left: 0.255em;"><span style="display: inline-block; position: relative; width: 0.91em; height: 0px;"><span style="position: absolute; clip: rect(3.178em 1000.41em 4.337em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-112" style="font-family: STIXGeneral-Italic;">f<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.154em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 0.305em;"><span class="mi" id="MathJax-Span-113" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">m</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mo" id="MathJax-Span-114" style="vertical-align: 2.22em;"><span style="display: inline-block; position: relative; width: 0.456em; height: 0px;"><span style="position: absolute; font-family: STIXSizeOneSym; top: -3.274em; left: 0.003em;">⎞<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; font-family: STIXSizeOneSym; top: -0.401em; left: 0.003em;">⎠<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -2.316em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -1.358em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mo" id="MathJax-Span-115" style="font-family: STIXGeneral-Regular; padding-left: 0.255em;">+</span><span class="mfrac" id="MathJax-Span-116" style="padding-left: 0.255em;"><span style="display: inline-block; position: relative; width: 3.682em; height: 0px; margin-right: 0.103em; margin-left: 0.103em;"><span style="position: absolute; clip: rect(3.329em 1000.66em 4.287em -999.997em); top: -4.534em; left: 50%; margin-left: -0.3em;"><span class="mrow" id="MathJax-Span-117"><span class="msub" id="MathJax-Span-118"><span style="display: inline-block; position: relative; width: 0.658em; height: 0px;"><span style="position: absolute; clip: rect(3.329em 1000.3em 4.287em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-119" style="font-size: 70.7%; font-family: STIXGeneral-Italic;">f<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.103em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 0.204em;"><span class="mi" id="MathJax-Span-120" style="font-size: 50%; font-family: STIXGeneral-Regular;">m</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(2.22em 1003.53em 4.337em -999.997em); top: -2.467em; left: 50%; margin-left: -1.762em;"><span class="mrow" id="MathJax-Span-121"><span class="mn" id="MathJax-Span-122" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">1</span><span class="mo" id="MathJax-Span-123" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">+</span><span class="mrow" id="MathJax-Span-124"><span class="msub" id="MathJax-Span-125"><span style="display: inline-block; position: relative; width: 1.011em; height: 0px;"><span style="position: absolute; clip: rect(3.38em 1000.66em 4.236em -999.997em); top: -3.979em; left: 0.003em;"><span class="mrow" id="MathJax-Span-126"><span class="mo" id="MathJax-Span-127" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">[</span><span class="mi" id="MathJax-Span-128" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">I</span><span class="mo" id="MathJax-Span-129" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">]</span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 0.708em;"><span class="mi" id="MathJax-Span-130" style="font-size: 50%; font-family: STIXGeneral-Regular;">u</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span class="mo" id="MathJax-Span-131" style="font-size: 238.6%; font-family: STIXGeneral-Regular;">/</span><span class="msub" id="MathJax-Span-132"><span style="display: inline-block; position: relative; width: 1.061em; height: 0px;"><span style="position: absolute; clip: rect(3.38em 1000.51em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-133" style="font-size: 70.7%; font-family: STIXGeneral-Italic;">K<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.053em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.879em; left: 0.456em;"><span class="mrow" id="MathJax-Span-134"><span class="mi" id="MathJax-Span-135" style="font-size: 50%; font-family: STIXGeneral-Regular;">i</span><span class="mo" id="MathJax-Span-136" style="font-size: 50%; font-family: STIXGeneral-Regular;">,</span><span class="mi" id="MathJax-Span-137" style="font-size: 50%; font-family: STIXGeneral-Regular;">u</span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(0.859em 1003.68em 1.212em -999.997em); top: -1.258em; left: 0.003em;"><span style="display: inline-block; overflow: hidden; vertical-align: 0.003em; border-top-width: 1.3px; border-top-style: solid; width: 3.682em; height: 0px;"></span><span style="display: inline-block; width: 0px; height: 1.061em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 4.892em;"></span></span><span style="position: absolute; clip: rect(0.859em 1008.72em 1.212em -999.997em); top: -1.258em; left: 0.003em;"><span style="display: inline-block; overflow: hidden; vertical-align: 0.003em; border-top-width: 1.3px; border-top-style: solid; width: 8.722em; height: 0px;"></span><span style="display: inline-block; width: 0px; height: 1.061em;"></span></span></span></span><span class="mo" id="MathJax-Span-138" style="vertical-align: 4.337em;"><span style="display: inline-block; position: relative; width: 0.456em; height: 0px;"><span style="position: absolute; font-family: STIXSizeOneSym; top: -3.274em; left: 0.003em;">⎞<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; font-family: STIXSizeOneSym; top: 3.934em; left: 0.003em;">⎠<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -2.366em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -1.459em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -0.552em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 0.305em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 1.212em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 2.119em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 3.027em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 6.454em;"></span></span></span><span style="display: inline-block; overflow: hidden; vertical-align: -4.809em; border-left-width: 0px; border-left-style: solid; width: 0px; height: 10.316em;"></span></span></nobr></span></div><script type="math/mml" id="MathJax-Element-3"><math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="block" id="M3" overflow="scroll"><mrow><mfrac><mrow><msub><mi>AUC</mi><mi mathvariant="normal">i</mi></msub></mrow><mi>AUC</mi></mfrac><mo>=</mo><mrow><mo stretchy="true">(</mo><mfrac><mrow><msub><mi>F</mi><mrow><mi mathvariant="normal">g</mi><mo>,</mo><mi mathvariant="normal">i</mi></mrow></msub></mrow><mrow><msub><mi>F</mi><mi mathvariant="normal">g</mi></msub></mrow></mfrac><mo stretchy="true">)</mo></mrow><mo>⋅</mo><mrow><mo stretchy="true">(</mo><mfrac><mn>1</mn><mrow><mo>(</mo><mn>1</mn><mo>−</mo><msub><mi>f</mi><mi mathvariant="normal">m</mi></msub><mo>)</mo><mo>+</mo><mfrac><mrow><msub><mi>f</mi><mi mathvariant="normal">m</mi></msub></mrow><mrow><mn>1</mn><mo>+</mo><mrow><msub><mrow><mo>[</mo><mi mathvariant="normal">I</mi><mo>]</mo></mrow><mi mathvariant="normal">u</mi></msub></mrow><mo mathsize="3em">/</mo><msub><mi>K</mi><mrow><mi mathvariant="normal">i</mi><mo>,</mo><mi mathvariant="normal">u</mi></mrow></msub></mrow></mfrac></mrow></mfrac><mo stretchy="true">)</mo></mrow></mrow></math></script></div><div class="l">(3)</div></div><p>
in which <em>F</em><sub>g</sub> indicates the fraction of the dose escaping metabolism in the gut wall,<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946206" role="button" aria-expanded="false" aria-haspopup="true">16</a></sup> was used to predict the effect of ITZ on the AUC of oral MDZ, with adjustment for multiple inhibitors as described by <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#FD5" rid="FD5" class=" disp-formula">Equation 5</a>. The ratio of inhibited to uninhibited <em>F</em><sub>g</sub> was calculated using <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#FD4" rid="FD4" class=" disp-formula">Equation 4</a> (ref. <sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946197" role="button" aria-expanded="false" aria-haspopup="true">16</a></sup>):
</p><div class="disp-formula" id="FD4"><div class="f"><span class="MathJax_Preview"></span><div class="MathJax_Display" style="text-align: center;"><span class="MathJax" id="MathJax-Element-4-Frame" tabindex="0"><nobr><span class="math" id="M4" overflow="scroll" role="math" style="width: 17.089em; display: inline-block;"><span style="display: inline-block; position: relative; width: 13.763em; height: 0px; font-size: 124%;"><span style="position: absolute; clip: rect(0.96em 1013.76em 5.295em -999.997em); top: -2.518em; left: 0.003em;"><span class="mrow" id="MathJax-Span-140"><span class="mrow" id="MathJax-Span-141"><span class="mfrac" id="MathJax-Span-142"><span style="display: inline-block; position: relative; width: 1.515em; height: 0px; margin-right: 0.103em; margin-left: 0.103em;"><span style="position: absolute; clip: rect(3.178em 1001.41em 4.438em -999.997em); top: -4.735em; left: 50%; margin-left: -0.703em;"><span class="mrow" id="MathJax-Span-143"><span class="msub" id="MathJax-Span-144"><span style="display: inline-block; position: relative; width: 1.414em; height: 0px;"><span style="position: absolute; clip: rect(3.178em 1000.66em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-145" style="font-family: STIXGeneral-Italic;">F<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.053em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 0.607em;"><span class="mrow" id="MathJax-Span-146"><span class="mi" id="MathJax-Span-147" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">g</span><span class="mo" id="MathJax-Span-148" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">,</span><span class="mi" id="MathJax-Span-149" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">i</span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(3.178em 1001.06em 4.438em -999.997em); top: -3.274em; left: 50%; margin-left: -0.502em;"><span class="mrow" id="MathJax-Span-150"><span class="msub" id="MathJax-Span-151"><span style="display: inline-block; position: relative; width: 1.061em; height: 0px;"><span style="position: absolute; clip: rect(3.178em 1000.66em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-152" style="font-family: STIXGeneral-Italic;">F<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.053em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 0.607em;"><span class="mi" id="MathJax-Span-153" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">g</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(0.859em 1001.51em 1.212em -999.997em); top: -1.258em; left: 0.003em;"><span style="display: inline-block; overflow: hidden; vertical-align: 0.003em; border-top-width: 1.3px; border-top-style: solid; width: 1.515em; height: 0px;"></span><span style="display: inline-block; width: 0px; height: 1.061em;"></span></span></span></span><span class="mo" id="MathJax-Span-154" style="font-family: STIXGeneral-Regular; padding-left: 0.305em;">=</span><span class="mfrac" id="MathJax-Span-155" style="padding-left: 0.305em;"><span style="display: inline-block; position: relative; width: 6.303em; height: 0px; margin-right: 0.103em; margin-left: 0.103em;"><span style="position: absolute; clip: rect(3.178em 1000.41em 4.136em -999.997em); top: -4.635em; left: 50%; margin-left: -0.249em;"><span class="mn" id="MathJax-Span-156" style="font-family: STIXGeneral-Regular;">1</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(2.976em 1006.1em 4.488em -999.997em); top: -3.173em; left: 50%; margin-left: -3.072em;"><span class="mrow" id="MathJax-Span-157"><span class="msub" id="MathJax-Span-158"><span style="display: inline-block; position: relative; width: 1.061em; height: 0px;"><span style="position: absolute; clip: rect(3.178em 1000.66em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-159" style="font-family: STIXGeneral-Italic;">F<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.053em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 0.607em;"><span class="mi" id="MathJax-Span-160" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">g</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mo" id="MathJax-Span-161" style="font-family: STIXGeneral-Regular; padding-left: 0.255em;">+</span><span class="mo" id="MathJax-Span-162" style="vertical-align: -0.199em; padding-left: 0.255em;"><span style="font-family: STIXSizeOneSym;">(</span></span><span class="mn" id="MathJax-Span-163" style="font-family: STIXGeneral-Regular;">1</span><span class="mo" id="MathJax-Span-164" style="font-family: STIXGeneral-Regular; padding-left: 0.255em;">−</span><span class="msub" id="MathJax-Span-165" style="padding-left: 0.255em;"><span style="display: inline-block; position: relative; width: 1.061em; height: 0px;"><span style="position: absolute; clip: rect(3.178em 1000.66em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-166" style="font-family: STIXGeneral-Italic;">F<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.053em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 0.607em;"><span class="mi" id="MathJax-Span-167" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">g</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mo" id="MathJax-Span-168" style="vertical-align: -0.199em;"><span style="font-family: STIXSizeOneSym;">)</span></span><span class="mo" id="MathJax-Span-169" style="font-family: STIXGeneral-Regular;">⋅</span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(0.859em 1006.3em 1.212em -999.997em); top: -1.258em; left: 0.003em;"><span style="display: inline-block; overflow: hidden; vertical-align: 0.003em; border-top-width: 1.3px; border-top-style: solid; width: 6.303em; height: 0px;"></span><span style="display: inline-block; width: 0px; height: 1.061em;"></span></span></span></span><span class="mfrac" id="MathJax-Span-170"><span style="display: inline-block; position: relative; width: 4.035em; height: 0px; margin-right: 0.103em; margin-left: 0.103em;"><span style="position: absolute; clip: rect(3.178em 1000.41em 4.136em -999.997em); top: -4.635em; left: 50%; margin-left: -0.249em;"><span class="mn" id="MathJax-Span-171" style="font-family: STIXGeneral-Regular;">1</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(2.926em 1003.93em 5.9em -999.997em); top: -3.122em; left: 50%; margin-left: -1.963em;"><span class="mfrac" id="MathJax-Span-172"><span style="display: inline-block; position: relative; width: 3.682em; height: 0px; margin-right: 0.103em; margin-left: 0.103em;"><span style="position: absolute; clip: rect(3.38em 1000.3em 4.136em -999.997em); top: -4.383em; left: 50%; margin-left: -0.199em;"><span class="mn" id="MathJax-Span-173" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">1</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(2.22em 1003.53em 4.388em -999.997em); top: -2.467em; left: 50%; margin-left: -1.762em;"><span class="mrow" id="MathJax-Span-174"><span class="mn" id="MathJax-Span-175" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">1</span><span class="mo" id="MathJax-Span-176" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">+</span><span class="mrow" id="MathJax-Span-177"><span class="msub" id="MathJax-Span-178"><span style="display: inline-block; position: relative; width: 1.011em; height: 0px;"><span style="position: absolute; clip: rect(3.38em 1000.66em 4.236em -999.997em); top: -3.979em; left: 0.003em;"><span class="mrow" id="MathJax-Span-179"><span class="mo" id="MathJax-Span-180" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">[</span><span class="mi" id="MathJax-Span-181" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">I</span><span class="mo" id="MathJax-Span-182" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">]</span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 0.708em;"><span class="mi" id="MathJax-Span-183" style="font-size: 50%; font-family: STIXGeneral-Regular;">g</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span class="mo" id="MathJax-Span-184" style="font-size: 238.6%; font-family: STIXGeneral-Regular;">/</span><span class="msub" id="MathJax-Span-185"><span style="display: inline-block; position: relative; width: 1.061em; height: 0px;"><span style="position: absolute; clip: rect(3.38em 1000.51em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-186" style="font-size: 70.7%; font-family: STIXGeneral-Italic;">K<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.053em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.879em; left: 0.456em;"><span class="mrow" id="MathJax-Span-187"><span class="mi" id="MathJax-Span-188" style="font-size: 50%; font-family: STIXGeneral-Regular;">i</span><span class="mo" id="MathJax-Span-189" style="font-size: 50%; font-family: STIXGeneral-Regular;">,</span><span class="mi" id="MathJax-Span-190" style="font-size: 50%; font-family: STIXGeneral-Regular;">g</span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(0.859em 1003.68em 1.212em -999.997em); top: -1.258em; left: 0.003em;"><span style="display: inline-block; overflow: hidden; vertical-align: 0.003em; border-top-width: 1.3px; border-top-style: solid; width: 3.682em; height: 0px;"></span><span style="display: inline-block; width: 0px; height: 1.061em;"></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(0.859em 1004.03em 1.212em -999.997em); top: -1.258em; left: 0.003em;"><span style="display: inline-block; overflow: hidden; vertical-align: 0.003em; border-top-width: 1.3px; border-top-style: solid; width: 4.035em; height: 0px;"></span><span style="display: inline-block; width: 0px; height: 1.061em;"></span></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.523em;"></span></span></span><span style="display: inline-block; overflow: hidden; vertical-align: -3.309em; border-left-width: 0px; border-left-style: solid; width: 0px; height: 5.128em;"></span></span></nobr></span></div><script type="math/mml" id="MathJax-Element-4"><math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="block" id="M4" overflow="scroll"><mrow><mfrac><mrow><msub><mi>F</mi><mrow><mi mathvariant="normal">g</mi><mo>,</mo><mi mathvariant="normal">i</mi></mrow></msub></mrow><mrow><msub><mi>F</mi><mi mathvariant="normal">g</mi></msub></mrow></mfrac><mo>=</mo><mfrac><mn>1</mn><mrow><msub><mi>F</mi><mi mathvariant="normal">g</mi></msub><mo>+</mo><mo>(</mo><mn>1</mn><mo>−</mo><msub><mi>F</mi><mi mathvariant="normal">g</mi></msub><mo>)</mo><mo>⋅</mo></mrow></mfrac><mfrac><mn>1</mn><mfrac><mn>1</mn><mrow><mn>1</mn><mo>+</mo><mrow><msub><mrow><mo>[</mo><mi mathvariant="normal">I</mi><mo>]</mo></mrow><mi mathvariant="normal">g</mi></msub></mrow><mo mathsize="3em">/</mo><msub><mi>K</mi><mrow><mi mathvariant="normal">i</mi><mo>,</mo><mi mathvariant="normal">g</mi></mrow></msub></mrow></mfrac></mfrac></mrow></math></script></div><div class="l">(4)</div></div><p>
with adjustment for multiple inhibitors. The inhibitory potency (<em>K</em><sub>i</sub>) of ITZ and its metabolites was assumed to be the same in the liver and gut, and the human liver microsomal IC<sub>50</sub> values were used for predictions related to both gut and liver. Because MDZ was administered 4 h after ITZ (which is ~3 h after ITZ <em>t</em><sub>max</sub> in our previous study with the same formulation of ITZ<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_286160543" role="button" aria-expanded="false" aria-haspopup="true">8</a></sup>), we took the value of the systemic concentration of ITZ and its metabolites as [I]<sub>g</sub>.</p></div><div id="P31"><p>For all predictions, the average unbound plasma concentration of ITZ alone or the sum of the average concentrations of ITZ and its metabolites were analyzed for [I]. The contribution of ITZ alone and of the circulating inhibitory metabolites to overall inhibition was
</p><div class="disp-formula" id="FD5"><div class="f"><span class="MathJax_Preview"></span><div class="MathJax_Display" style="text-align: center;"><span class="MathJax" id="MathJax-Element-5-Frame" tabindex="0"><nobr><span class="math" id="M5" overflow="scroll" role="math" style="width: 16.787em; display: inline-block;"><span style="display: inline-block; position: relative; width: 13.511em; height: 0px; font-size: 124%;"><span style="position: absolute; clip: rect(-5.743em 1013.31em 9.579em -999.997em); top: -2.165em; left: 0.003em;"><span class="mrow" id="MathJax-Span-192"><span class="mtable" id="MathJax-Span-193" style="padding-right: 0.154em; padding-left: 0.154em;"><span style="display: inline-block; position: relative; width: 13.158em; height: 0px;"><span style="position: absolute; clip: rect(4.74em 1002.98em 13.813em -999.997em); top: -9.725em; left: 0.003em;"><span style="display: inline-block; position: relative; width: 3.027em; height: 0px;"><span style="position: absolute; clip: rect(2.825em 1002.98em 4.539em -999.997em); top: -7.81em; right: 0.003em;"><span class="mtd" id="MathJax-Span-194"><span class="mrow" id="MathJax-Span-195"><span class="mrow" id="MathJax-Span-196"><span class="mfrac" id="MathJax-Span-197"><span style="display: inline-block; position: relative; width: 1.817em; height: 0px; margin-right: 0.103em; margin-left: 0.103em;"><span style="position: absolute; clip: rect(3.38em 1001.67em 4.236em -999.997em); top: -4.483em; left: 50%; margin-left: -0.854em;"><span class="mrow" id="MathJax-Span-198"><span class="msub" id="MathJax-Span-199"><span style="display: inline-block; position: relative; width: 1.666em; height: 0px;"><span style="position: absolute; clip: rect(3.38em 1001.46em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-200" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">AUC</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.879em; left: 1.515em;"><span class="mi" id="MathJax-Span-201" style="font-size: 50%; font-family: STIXGeneral-Regular;">i</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(3.38em 1001.46em 4.136em -999.997em); top: -3.576em; left: 50%; margin-left: -0.754em;"><span class="mi" id="MathJax-Span-202" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">AUC</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(0.859em 1001.82em 1.212em -999.997em); top: -1.258em; left: 0.003em;"><span style="display: inline-block; overflow: hidden; vertical-align: 0.003em; border-top-width: 1.3px; border-top-style: solid; width: 1.817em; height: 0px;"></span><span style="display: inline-block; width: 0px; height: 1.061em;"></span></span></span></span><span class="mo" id="MathJax-Span-203" style="font-family: STIXGeneral-Regular; padding-left: 0.305em;">=</span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(3.833em 1000em 4.136em -999.997em); top: -0.048em; right: 0.003em;"><span class="mtd" id="MathJax-Span-251"><span class="mrow" id="MathJax-Span-252"><span class="mrow" id="MathJax-Span-253"></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span><span style="display: inline-block; width: 0px; height: 9.73em;"></span></span><span style="position: absolute; clip: rect(8.117em 1009.18em 23.44em -999.997em); top: -16.026em; left: 3.934em;"><span style="display: inline-block; position: relative; width: 9.226em; height: 0px;"><span style="position: absolute; clip: rect(4.236em 1009.18em 11.898em -999.997em); top: -12.145em; left: 0.003em;"><span class="mtd" id="MathJax-Span-204"><span class="mrow" id="MathJax-Span-205"><span class="mrow" id="MathJax-Span-206"><span class="mo" id="MathJax-Span-207" style="vertical-align: 3.934em;"><span style="display: inline-block; position: relative; width: 0.456em; height: 0px;"><span style="position: absolute; font-family: STIXSizeOneSym; top: -3.274em; left: 0.003em;">⎛<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; font-family: STIXSizeOneSym; top: 3.077em; left: 0.003em;">⎝<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -2.366em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -1.459em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -0.552em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 0.355em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 1.263em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 2.17em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mfrac" id="MathJax-Span-208"><span style="display: inline-block; position: relative; width: 8.067em; height: 0px; margin-right: 0.103em; margin-left: 0.103em;"><span style="position: absolute; clip: rect(3.38em 1000.3em 4.136em -999.997em); top: -4.383em; left: 50%; margin-left: -0.199em;"><span class="mn" id="MathJax-Span-209" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">1</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(2.472em 1007.97em 6.253em -999.997em); top: -2.719em; left: 50%; margin-left: -3.979em;"><span class="mrow" id="MathJax-Span-210"><span class="msub" id="MathJax-Span-211"><span style="display: inline-block; position: relative; width: 0.759em; height: 0px;"><span style="position: absolute; clip: rect(3.38em 1000.46em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-212" style="font-size: 70.7%; font-family: STIXGeneral-Italic;">F<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.003em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.879em; left: 0.456em;"><span class="mi" id="MathJax-Span-213" style="font-size: 50%; font-family: STIXGeneral-Regular;">g</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mo" id="MathJax-Span-214" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">+</span><span class="mo" id="MathJax-Span-215" style="vertical-align: 1.918em;"><span style="display: inline-block; position: relative; width: 0.305em; height: 0px;"><span style="position: absolute; top: -3.475em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎛</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -0.653em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎝</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -2.921em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎜</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -2.366em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎜</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -1.812em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎜</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -1.258em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎜</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mn" id="MathJax-Span-216" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">1</span><span class="mo" id="MathJax-Span-217" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">−</span><span class="msub" id="MathJax-Span-218"><span style="display: inline-block; position: relative; width: 0.759em; height: 0px;"><span style="position: absolute; clip: rect(3.38em 1000.46em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-219" style="font-size: 70.7%; font-family: STIXGeneral-Italic;">F<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.003em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.879em; left: 0.456em;"><span class="mi" id="MathJax-Span-220" style="font-size: 50%; font-family: STIXGeneral-Regular;">g</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mo" id="MathJax-Span-221" style="vertical-align: 1.918em;"><span style="display: inline-block; position: relative; width: 0.305em; height: 0px;"><span style="position: absolute; top: -3.475em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎞</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -0.653em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎠</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -2.921em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎟</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -2.366em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎟</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -1.812em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎟</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -1.258em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎟</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mo" id="MathJax-Span-222" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">⋅</span><span class="mfrac" id="MathJax-Span-223"><span style="display: inline-block; position: relative; width: 4.085em; height: 0px; margin-right: 0.103em; margin-left: 0.103em;"><span style="position: absolute; clip: rect(3.48em 1000.2em 4.136em -999.997em); top: -4.332em; left: 50%; margin-left: -0.098em;"><span class="mn" id="MathJax-Span-224" style="font-size: 50%; font-family: STIXGeneral-Regular;">1</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(2.371em 1003.98em 4.287em -999.997em); top: -2.518em; left: 50%; margin-left: -1.963em;"><span class="mrow" id="MathJax-Span-225"><span class="mn" id="MathJax-Span-226" style="font-size: 50%; font-family: STIXGeneral-Regular;">1</span><span class="mo" id="MathJax-Span-227" style="font-size: 50%; font-family: STIXGeneral-Regular;">+</span><span class="msubsup" id="MathJax-Span-228"><span style="display: inline-block; position: relative; width: 3.38em; height: 0px;"><span style="position: absolute; clip: rect(3.43em 1000.41em 4.287em -999.997em); top: -3.979em; left: 0.003em;"><span class="mo" id="MathJax-Span-229" style="font-size: 50%; font-family: STIXGeneral-Regular; vertical-align: 0.003em;">∑</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -4.332em; left: 0.456em;"><span class="mrow" id="MathJax-Span-230"><span class="mrow" id="MathJax-Span-231"><span class="msub" id="MathJax-Span-232"><span style="display: inline-block; position: relative; width: 1.162em; height: 0px;"><span style="position: absolute; clip: rect(3.48em 1000.46em 4.236em -999.997em); top: -3.979em; left: 0.003em;"><span class="mrow" id="MathJax-Span-233"><span class="mo" id="MathJax-Span-234" style="font-size: 50%; font-family: STIXGeneral-Regular;">[</span><span class="mi" id="MathJax-Span-235" style="font-size: 50%; font-family: STIXGeneral-Regular;">I</span><span class="mo" id="MathJax-Span-236" style="font-size: 50%; font-family: STIXGeneral-Regular;">]</span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.879em; left: 0.507em;"><span class="mrow" id="MathJax-Span-237"><span class="mi" id="MathJax-Span-238" style="font-size: 50%; font-family: STIXGeneral-Regular;">u</span><span class="mo" id="MathJax-Span-239" style="font-size: 50%; font-family: STIXGeneral-Regular;">,</span><span class="mi" id="MathJax-Span-240" style="font-size: 50%; font-family: STIXGeneral-Regular;">g</span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span class="mo" id="MathJax-Span-241" style="font-size: 168.8%; font-family: STIXGeneral-Regular;">/</span><span class="msub" id="MathJax-Span-242"><span style="display: inline-block; position: relative; width: 1.263em; height: 0px;"><span style="position: absolute; clip: rect(3.531em 1000.36em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-243" style="font-size: 50%; font-family: STIXGeneral-Italic;">K<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.053em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 0.355em;"><span class="mrow" id="MathJax-Span-244"><span class="mi" id="MathJax-Span-245" style="font-size: 50%; font-family: STIXGeneral-Regular;">i</span><span class="mo" id="MathJax-Span-246" style="font-size: 50%; font-family: STIXGeneral-Regular;">,</span><span class="mi" id="MathJax-Span-247" style="font-size: 50%; font-family: STIXGeneral-Regular;">u</span><span class="mo" id="MathJax-Span-248" style="font-size: 50%; font-family: STIXGeneral-Regular;">,</span><span class="mi" id="MathJax-Span-249" style="font-size: 50%; font-family: STIXGeneral-Regular;">g</span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(0.859em 1004.09em 1.212em -999.997em); top: -1.207em; left: 0.003em;"><span style="display: inline-block; overflow: hidden; vertical-align: 0.003em; border-top-width: 1.3px; border-top-style: solid; width: 4.085em; height: 0px;"></span><span style="display: inline-block; width: 0px; height: 1.061em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 4.539em;"></span></span><span style="position: absolute; clip: rect(0.859em 1008.07em 1.212em -999.997em); top: -1.258em; left: 0.003em;"><span style="display: inline-block; overflow: hidden; vertical-align: 0.003em; border-top-width: 1.3px; border-top-style: solid; width: 8.067em; height: 0px;"></span><span style="display: inline-block; width: 0px; height: 1.061em;"></span></span></span></span><span class="mo" id="MathJax-Span-250" style="vertical-align: 3.934em;"><span style="display: inline-block; position: relative; width: 0.456em; height: 0px;"><span style="position: absolute; font-family: STIXSizeOneSym; top: -3.274em; left: 0.003em;">⎞<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; font-family: STIXSizeOneSym; top: 3.077em; left: 0.003em;">⎠<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -2.366em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -1.459em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -0.552em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 0.355em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 1.263em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 2.17em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 8.319em;"></span></span><span style="position: absolute; clip: rect(4.186em 1007.87em 11.646em -999.997em); top: -4.231em; left: 0.003em;"><span class="mtd" id="MathJax-Span-254"><span class="mrow" id="MathJax-Span-255"><span class="mrow" id="MathJax-Span-256"><span class="mo" id="MathJax-Span-257" style="font-family: STIXGeneral-Regular;">⋅</span><span class="mrow" id="MathJax-Span-258" style="padding-left: 0.204em;"><span class="mo" id="MathJax-Span-259" style="vertical-align: 3.833em;"><span style="display: inline-block; position: relative; width: 0.456em; height: 0px;"><span style="position: absolute; font-family: STIXSizeOneSym; top: -3.274em; left: 0.003em;">⎛<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; font-family: STIXSizeOneSym; top: 2.926em; left: 0.003em;">⎝<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -2.417em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -1.51em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -0.653em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 0.255em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 1.162em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 2.019em; left: 0.003em;">⎜<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mfrac" id="MathJax-Span-260"><span style="display: inline-block; position: relative; width: 6.303em; height: 0px; margin-right: 0.103em; margin-left: 0.103em;"><span style="position: absolute; clip: rect(3.38em 1000.3em 4.136em -999.997em); top: -4.383em; left: 50%; margin-left: -0.199em;"><span class="mn" id="MathJax-Span-261" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">1</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(2.371em 1006.2em 6.152em -999.997em); top: -2.618em; left: 50%; margin-left: -3.072em;"><span class="mrow" id="MathJax-Span-262"><span class="mo" id="MathJax-Span-263" style="vertical-align: 1.918em;"><span style="display: inline-block; position: relative; width: 0.305em; height: 0px;"><span style="position: absolute; top: -3.475em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎛</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -0.754em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎝</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -2.921em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎜</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -2.417em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎜</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -1.862em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎜</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -1.308em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎜</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mn" id="MathJax-Span-264" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">1</span><span class="mo" id="MathJax-Span-265" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">−</span><span class="msub" id="MathJax-Span-266"><span style="display: inline-block; position: relative; width: 0.658em; height: 0px;"><span style="position: absolute; clip: rect(3.329em 1000.3em 4.287em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-267" style="font-size: 70.7%; font-family: STIXGeneral-Italic;">f<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.103em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 0.204em;"><span class="mi" id="MathJax-Span-268" style="font-size: 50%; font-family: STIXGeneral-Regular;">m</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mo" id="MathJax-Span-269" style="vertical-align: 1.918em;"><span style="display: inline-block; position: relative; width: 0.305em; height: 0px;"><span style="position: absolute; top: -3.475em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎞</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -0.754em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎠</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -2.921em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎟</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -2.417em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎟</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -1.862em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎟</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -1.308em; left: 0.003em;"><span style="font-size: 70.7%; font-family: STIXSizeOneSym;">⎟</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span><span class="mo" id="MathJax-Span-270" style="font-size: 70.7%; font-family: STIXGeneral-Regular;">+</span><span class="mfrac" id="MathJax-Span-271"><span style="display: inline-block; position: relative; width: 3.329em; height: 0px; margin-right: 0.103em; margin-left: 0.103em;"><span style="position: absolute; clip: rect(3.48em 1000.56em 4.287em -999.997em); top: -4.433em; left: 50%; margin-left: -0.3em;"><span class="mrow" id="MathJax-Span-272"><span class="msub" id="MathJax-Span-273"><span style="display: inline-block; position: relative; width: 0.557em; height: 0px;"><span style="position: absolute; clip: rect(3.48em 1000.2em 4.236em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-274" style="font-size: 50%; font-family: STIXGeneral-Italic;">f<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.053em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 0.154em;"><span class="mi" id="MathJax-Span-275" style="font-size: 50%; font-family: STIXGeneral-Regular;">m</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(2.422em 1003.23em 4.287em -999.997em); top: -2.568em; left: 50%; margin-left: -1.61em;"><span class="mrow" id="MathJax-Span-276"><span class="mn" id="MathJax-Span-277" style="font-size: 50%; font-family: STIXGeneral-Regular;">1</span><span class="mo" id="MathJax-Span-278" style="font-size: 50%; font-family: STIXGeneral-Regular;">+</span><span class="msubsup" id="MathJax-Span-279"><span style="display: inline-block; position: relative; width: 2.623em; height: 0px;"><span style="position: absolute; clip: rect(3.43em 1000.41em 4.287em -999.997em); top: -3.979em; left: 0.003em;"><span class="mo" id="MathJax-Span-280" style="font-size: 50%; font-family: STIXGeneral-Regular; vertical-align: 0.003em;">∑</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -4.282em; left: 0.456em;"><span class="mrow" id="MathJax-Span-281"><span class="mrow" id="MathJax-Span-282"><span class="msub" id="MathJax-Span-283"><span style="display: inline-block; position: relative; width: 0.809em; height: 0px;"><span style="position: absolute; clip: rect(3.48em 1000.46em 4.236em -999.997em); top: -3.979em; left: 0.003em;"><span class="mrow" id="MathJax-Span-284"><span class="mo" id="MathJax-Span-285" style="font-size: 50%; font-family: STIXGeneral-Regular;">[</span><span class="mi" id="MathJax-Span-286" style="font-size: 50%; font-family: STIXGeneral-Regular;">I</span><span class="mo" id="MathJax-Span-287" style="font-size: 50%; font-family: STIXGeneral-Regular;">]</span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.879em; left: 0.507em;"><span class="mi" id="MathJax-Span-288" style="font-size: 50%; font-family: STIXGeneral-Regular;">u</span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span class="mo" id="MathJax-Span-289" style="font-size: 168.8%; font-family: STIXGeneral-Regular;">/</span><span class="msub" id="MathJax-Span-290"><span style="display: inline-block; position: relative; width: 0.91em; height: 0px;"><span style="position: absolute; clip: rect(3.531em 1000.36em 4.136em -999.997em); top: -3.979em; left: 0.003em;"><span class="mi" id="MathJax-Span-291" style="font-size: 50%; font-family: STIXGeneral-Italic;">K<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.053em;"></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; top: -3.828em; left: 0.355em;"><span class="mrow" id="MathJax-Span-292"><span class="mi" id="MathJax-Span-293" style="font-size: 50%; font-family: STIXGeneral-Regular;">i</span><span class="mo" id="MathJax-Span-294" style="font-size: 50%; font-family: STIXGeneral-Regular;">,</span><span class="mi" id="MathJax-Span-295" style="font-size: 50%; font-family: STIXGeneral-Regular;">u</span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; clip: rect(0.859em 1003.33em 1.212em -999.997em); top: -1.207em; left: 0.003em;"><span style="display: inline-block; overflow: hidden; vertical-align: 0.003em; border-top-width: 1.3px; border-top-style: solid; width: 3.329em; height: 0px;"></span><span style="display: inline-block; width: 0px; height: 1.061em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 4.438em;"></span></span><span style="position: absolute; clip: rect(0.859em 1006.3em 1.212em -999.997em); top: -1.258em; left: 0.003em;"><span style="display: inline-block; overflow: hidden; vertical-align: 0.003em; border-top-width: 1.3px; border-top-style: solid; width: 6.303em; height: 0px;"></span><span style="display: inline-block; width: 0px; height: 1.061em;"></span></span></span></span><span class="mo" id="MathJax-Span-296" style="vertical-align: 3.833em;"><span style="display: inline-block; position: relative; width: 0.456em; height: 0px;"><span style="position: absolute; font-family: STIXSizeOneSym; top: -3.274em; left: 0.003em;">⎞<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="position: absolute; font-family: STIXSizeOneSym; top: 2.926em; left: 0.003em;">⎠<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -2.417em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -1.51em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: -0.653em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 0.255em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 1.162em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span><span style="font-family: STIXSizeOneSym; position: absolute; top: 2.019em; left: 0.003em;">⎟<span style="display: inline-block; width: 0px; height: 3.984em;"></span></span></span></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 8.168em;"></span></span></span><span style="display: inline-block; width: 0px; height: 16.031em;"></span></span></span></span></span><span style="display: inline-block; width: 0px; height: 2.17em;"></span></span></span><span style="display: inline-block; overflow: hidden; vertical-align: -9.059em; border-left-width: 0px; border-left-style: solid; width: 0px; height: 18.753em;"></span></span></nobr></span></div><script type="math/mml" id="MathJax-Element-5"><math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="block" id="M5" overflow="scroll"><mtable><mtr><mtd columnalign="right"><mrow><mfrac><mrow><msub><mi>AUC</mi><mi mathvariant="normal">i</mi></msub></mrow><mi>AUC</mi></mfrac><mo>=</mo></mrow></mtd><mtd columnalign="left"><mrow><mo stretchy="true">(</mo><mfrac><mn>1</mn><mrow><msub><mi>F</mi><mi mathvariant="normal">g</mi></msub><mo>+</mo><mo>(</mo><mn>1</mn><mo>−</mo><msub><mi>F</mi><mi mathvariant="normal">g</mi></msub><mo>)</mo><mo>⋅</mo><mfrac><mn>1</mn><mrow><mn>1</mn><mo>+</mo><msubsup><mo>∑</mo><mrow></mrow><mrow><mrow><msub><mrow><mo>[</mo><mi mathvariant="normal">I</mi><mo>]</mo></mrow><mrow><mi mathvariant="normal">u</mi><mo>,</mo><mi mathvariant="normal">g</mi></mrow></msub></mrow><mo mathsize="3em">/</mo><msub><mi>K</mi><mrow><mi mathvariant="normal">i</mi><mo>,</mo><mi mathvariant="normal">u</mi><mo>,</mo><mi mathvariant="normal">g</mi></mrow></msub></mrow></msubsup></mrow></mfrac></mrow></mfrac><mo stretchy="true">)</mo></mrow></mtd></mtr><mtr><mtd columnalign="right"><mrow></mrow></mtd><mtd columnalign="left"><mrow><mo>⋅</mo><mrow><mo stretchy="true">(</mo><mfrac><mn>1</mn><mrow><mo>(</mo><mn>1</mn><mo>−</mo><msub><mi>f</mi><mi mathvariant="normal">m</mi></msub><mo>)</mo><mo>+</mo><mfrac><mrow><msub><mi>f</mi><mi mathvariant="normal">m</mi></msub></mrow><mrow><mn>1</mn><mo>+</mo><msubsup><mo>∑</mo><mrow></mrow><mrow><mrow><msub><mrow><mo>[</mo><mi mathvariant="normal">I</mi><mo>]</mo></mrow><mi mathvariant="normal">u</mi></msub></mrow><mo mathsize="3em">/</mo><msub><mi>K</mi><mrow><mi mathvariant="normal">i</mi><mo>,</mo><mi mathvariant="normal">u</mi></mrow></msub></mrow></msubsup></mrow></mfrac></mrow></mfrac><mo stretchy="true">)</mo></mrow></mrow></mtd></mtr></mtable></math></script></div><div class="l">(5)</div></div><p>
determined using the sum of [I]/<em>K</em><sub>i</sub> values for ITZ and its metabolites according to <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#FD5" rid="FD5" class=" disp-formula">Equation 5</a>.</p></div><p id="P32">The fraction of MDZ elimination that occurs through CYP3A4 (<em>f</em><sub>m,CYP3A4</sub>) activity in the liver was assumed to be 93%.<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946188" role="button" aria-expanded="false" aria-haspopup="true">16</a></sup> Absorption of MDZ was assumed complete and an <em>F</em><sub>g</sub> value of 0.55 was used to determine intestinal first-pass metabolism of MDZ.<sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_213946207" role="button" aria-expanded="false" aria-haspopup="true">17</a></sup></p><p id="P33" class="p p-last">The accuracy of the predictions was evaluated for all interactions and for each dose level by comparing the magnitude of the observed interaction to the interactions predicted on the basis of considering ITZ alone or ITZ and its metabolites. A less-than-twofold error in predictions was considered accurate.</p></div></div><div id="SM" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-15"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-16">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="SMtitle">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>FigS1</h4><div class="sup-box half_rhythm" id="N0x299dc50N0x390a040"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/bin/NIHMS268021-supplement-FigS1.ppt">Click here to view.</a><sup>(122K, ppt)</sup></div></div><div class="sec suppmat" id="SD2"><h4>FigS2</h4><div class="sup-box half_rhythm" id="N0x299dc50N0x390a100"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/bin/NIHMS268021-supplement-FigS2.ppt">Click here to view.</a><sup>(143K, ppt)</sup></div></div></div><div id="S10" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-17"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-18">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S10title">ACKNOWLEDGMENTS</h2><div class="sec"><p id="__p1">This work was supported in part by National Institutes of Health grants P01GM32165 and t32GM007750 and Clinical and Translational Science Award UL1 RR025014. We thank Angela Hein for her assistance in study coordination and Wendel Nelson for helpful discussions regarding ITZ metabolism.</p></div></div><div id="__fn-groupid961553" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-19"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-20">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__fn-groupid961553title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN1"></p><p id="P34" class="p p-first-last"><strong>SUPPLEMENTARY MATERIAL</strong> is linked to the online version of the paper at <a href="http://www.nature.com/cpt" ref="reftype=extlink&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="pmc_ext">http://www.nature.com/cpt</a></p><p></p><p class="fn sec" id="FN2"></p><p id="P35" class="p p-first-last"><strong>CONFLICT OF INTEREST</strong> The authors declared no conflict of interest.</p><p></p></div></div><div id="__ref-listid1027907" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-21"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-22">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__ref-listid1027907title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="citation">Isoherranen N, Hachad H, Yeung CK, Levy RH. Qualitative analysis of the role of metabolites in inhibitory drug-drug interactions: literature evaluation based on the metabolism and transport drug interaction database. <span><span class="ref-journal">Chem. Res. Toxicol. </span>2009;<span class="ref-vol">22</span>:294–298.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755268/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/19216580" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="citation">Fujioka Y, Yeung CK, Hachad H, Levy RH, Isoherranen N. Analysis of the contribution of circulating metabolites to inhibitory drug-drug interactions: literature evaluation based on the metabolism and transport drug interaction database. <span><span class="ref-journal">Drug Metab Rev. </span>2009;<span class="ref-vol">41</span>(suppl. 3):69.</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="citation">Isoherranen N, Kunze KL, Allen KE, Nelson WL, Thummel KE. Role of itraconazole metabolites in CYP3A4 inhibition. <span><span class="ref-journal">Drug Metab. Dispos. </span>2004;<span class="ref-vol">32</span>:1121–1131.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15242978" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="citation">Stevens JC, Wrighton SA. Interaction of the enantiomers of fluoxetine and norfluoxetine with human liver cytochromes P450. <span><span class="ref-journal">J. Pharmacol. Exp. Ther. </span>1993;<span class="ref-vol">266</span>:964–971.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8355218" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="citation">Reese MJ, Wurm RM, Muir KT, Generaux GT, St John-Williams L, Mcconn DJ. An <em>in vitro</em> mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction. <span><span class="ref-journal">Drug Metab. Dispos. </span>2008;<span class="ref-vol">36</span>:1198–1201.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18420781" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="citation">Preskorn SH, Alderman J, Chung M, Harrison W, Messig M, Harris S. Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine. <span><span class="ref-journal">J. Clin. Psychopharmacol. </span>1994;<span class="ref-vol">14</span>:90–98.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8195463" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="citation">Sauer JM, et al.  Atomoxetine hydrochloride: clinical drug-drug interaction prediction and outcome. <span><span class="ref-journal">J. Pharmacol. Exp. Ther. </span>2004;<span class="ref-vol">308</span>:410–418.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/14610241" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="citation">Templeton IE, et al.  Contribution of itraconazole metabolites to inhibition of CYP3A4 <em>in vivo</em>. <span><span class="ref-journal">Clin. Pharmacol. Ther. </span>2008;<span class="ref-vol">83</span>:77–85.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488349/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17495874" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="citation">Olkkola KT, Ahonen J, Neuvonen PJ. The effect of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam. <span><span class="ref-journal">Anesth Analg (Baltimore) </span>1996;<span class="ref-vol">82</span>:511–516.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8623953" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="citation">Olkkola KT, Brunetto AV, Mattila MJ. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents. <span><span class="ref-journal">Clin. Pharmacokinet. </span>1994;<span class="ref-vol">26</span>:107–120.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8162655" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="citation">Ahonen J, Olkkola KT, Neuvonen PJ. Effect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers. <span><span class="ref-journal">Br. J. Clin. Pharmacol. </span>1995;<span class="ref-vol">40</span>:270–272.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1365108/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8527290" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="citation">Neuvonen PJ, Varhe A, Olkkola KT. The effect of ingestion time interval on the interaction between itraconazole and triazolam. <span><span class="ref-journal">Clin. Pharmacol. Ther. </span>1996;<span class="ref-vol">60</span>:326–331.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8841155" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="citation">Backman JT, Kivistö KT, Olkkola KT, Neuvonen PJ. The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin. <span><span class="ref-journal">Eur. J. Clin. Pharmacol. </span>1998;<span class="ref-vol">54</span>:53–58.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9591931" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="citation">Levy RH, Hachad H, Yao C, Ragueneau-Majlessi I. Relationship between extent of inhibition and inhibitor dose: literature evaluation based on the metabolism and transport drug interaction database. <span><span class="ref-journal">Curr. Drug Metab. </span>2003;<span class="ref-vol">4</span>:371–380.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/14529369" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="citation">Yao C, Kunze KL, Trager WF, Kharasch ED, Levy RH. Comparison of <em>in vitro</em> and <em>in vivo</em> inhibition potencies of fluvoxamine toward CYP2C19. <span><span class="ref-journal">Drug Metab. Dispos. </span>2003;<span class="ref-vol">31</span>:565–571.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12695344" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="citation">Obach RS, Walsky RL, Venkatakrishnan K, Gaman EA, Houston JB, Tremaine LM. The utility of <em>in vitro</em> cytochrome P450 inhibition data in the prediction of drug-drug interactions. <span><span class="ref-journal">J. Pharmacol. Exp. Ther. </span>2006;<span class="ref-vol">316</span>:336–348.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16192315" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="citation">Paine MF, et al.  First-pass metabolism of midazolam by the human intestine. <span><span class="ref-journal">Clin. Pharmacol. Ther. </span>1996;<span class="ref-vol">60</span>:14–24.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8689807" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#__abstractid690938title">Abstract</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#S1title">RESULTS</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#S2title">DISCUSSION</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#S3title">METHODS</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#SMtitle">Supplementary Material</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#S10title">ACKNOWLEDGMENTS</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#__fn-groupid961553title">Footnotes</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#__ref-listid1027907title">References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="try-button"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/?report=reader"><img src="./PMC3056523_files/3838809" alt="PubReader format: click here to try"></a></div><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/epub/">ePub (beta)</a></li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/pdf/nihms-268021.pdf">PDF (447K)</a></li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" data-citationid="PMC3056523" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3056523%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC3056523_files/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3056523%2F&amp;text=Accurate%20Prediction%20of%20Dose-Dependent%20CYP3A4%20Inhibition%20by%20Itraconazole%20and%20Its%20Metabolites%20From%20In%20Vitro%20Inhibition%20Data" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC3056523_files/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3056523%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC3056523_files/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="20739919" data-aiid="3056523" data-aid="3056523" data-iid="195058" data-domainid="319" data-domain="nihpa" data-accid="PMC3056523" data-md5="e0674b7d4e8f33fef9392484e798ff1b">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="pmfavad" toggles="ui-portlet_content-25" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-25" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input type="hidden" name="absid" id="absid" value="3056523"><div id="pubmed_favoritesad" class="empty" data-db="pmc">
<span role="menubar"><div class="ui-ncbisetswitch ltd-hover" role="menuitem" aria-expanded="false" aria-haspopup="true"><a href="http://www.ncbi.nlm.nih.gov/myncbi/collections/" class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" id="favList" data-jigconfig="destSelector:&#39;#favUL&#39;,starExists:true,createCollectionUrl:&#39;#&#39;,manageCollectionsUrl:&#39;/myncbi/collections/&#39;"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" title="View more options" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper"><ul id="favUL" class="ui-ncbisetswitch-options"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="http://www.ncbi.nlm.nih.gov/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input type="submit" class="button_apply" name="addtocollection" value="1"></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" toggles="ui-portlet_content-27" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-27" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/17386084" ref="reftype=relart&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) models.</a><span class="source">[Theor Biol Med Model. 2007]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-29" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Vossen M, Sevestre M, Niederalt C, Jang IJ, Willmann S, Edginton AN. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Theor Biol Med Model. 2007 Mar 26; 4:13. Epub 2007 Mar 26.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/17495874" ref="reftype=relart&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo.</a><span class="source">[Clin Pharmacol Ther. 2008]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-31" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Templeton IE, Thummel KE, Kharasch ED, Kunze KL, Hoffer C, Nelson WL, Isoherranen N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Pharmacol Ther. 2008 Jan; 83(1):77-85. Epub 2007 May 9.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/15242978" ref="reftype=relart&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Role of itraconazole metabolites in CYP3A4 inhibition.</a><span class="source">[Drug Metab Dispos. 2004]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-33" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Isoherranen N, Kunze KL, Allen KE, Nelson WL, Thummel KE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Drug Metab Dispos. 2004 Oct; 32(10):1121-31. Epub 2004 Jul 8.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/16415110" ref="reftype=relart&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Stereochemical aspects of itraconazole metabolism in vitro and in vivo.</a><span class="source">[Drug Metab Dispos. 2006]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-35" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kunze KL, Nelson WL, Kharasch ED, Thummel KE, Isoherranen N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Drug Metab Dispos. 2006 Apr; 34(4):583-90. Epub 2006 Jan 13.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/11259329" ref="reftype=relart&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Prediction of midazolam-CYP3A inhibitors interaction in the human liver from in vivo/in vitro absorption, distribution, and metabolism data.</a><span class="source">[Drug Metab Dispos. 2001]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-37" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Yamano K, Yamamoto K, Katashima M, Kotaki H, Takedomi S, Matsuo H, Ohtani H, Sawada Y, Iga T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Drug Metab Dispos. 2001 Apr; 29(4 Pt 1):443-52. </em>
</div>
</li>
</ul>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20739919&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20739919&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Cited by other articles in PMC</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-39" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-39" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574820/" ref="reftype=relart&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Ritonavir is the best alternative to ketoconazole as an index inhibitor of cytochrome P450-3A in drug–drug interaction studies</a><span class="source">[British Journal of Clinical Ph...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-41" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Greenblatt DJ, Harmatz JS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">British Journal of Clinical Pharmacology. 2015 Apr 28; 80(3)342-350</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456127/" ref="reftype=relart&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Evaluation of drug–drug interactions for oncology therapies: in vitro–in vivo extrapolation model-based risk assessment</a><span class="source">[British Journal of Clinical Ph...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-43" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Waters NJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">British Journal of Clinical Pharmacology. 2015 May 22; 79(6)946-958</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029899/" ref="reftype=relart&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Fluoxetine and norfluoxetine mediated complex drug-drug interactions: in vitro to in vivo correlation of effects on CYP2D6, CYP2C19 and CYP3A4</a><span class="source">[Clinical pharmacology and ther...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-45" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sager JE, Lutz JD, Foti RS, Davis C, Kunze KL, Isoherranen N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clinical pharmacology and therapeutics. 2014 Feb 25; 95(6)653-662</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834134/" ref="reftype=relart&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Stereoselective Inhibition of CYP2C19 and CYP3A4 by Fluoxetine and Its Metabolite: Implications for Risk Assessment of Multiple Time-Dependent Inhibitor Systems</a><span class="source">[Drug Metabolism and Dispositio...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-47" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lutz JD, VandenBrink BM, Babu KN, Nelson WL, Kunze KL, Isoherranen N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Drug Metabolism and Disposition. 2013 Dec; 41(12)2056-2065</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481835/" ref="reftype=relart&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Evaluation of 6β-hydroxycortisol, 6β-hydroxycortisone and their combination as endogenous probes for inhibition of CYP3A4 in vivo</a><span class="source">[Clinical pharmacology and ther...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-49" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Peng CC, Templeton I, Thummel KE, Davis C, Kunze KL, Isoherranen N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clinical pharmacology and therapeutics. 2011 Apr 13; 89(6)888-895</em>
</div>
</li>
</ul>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/citedby/" ref="reftype=relart&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|CitedBy&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-51" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-51" aria-hidden="false"><ul>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=pccompound&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pccompound&amp;IdsFromResult=3056523" ref="reftype=Compound&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Compound&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Compound</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-53" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Compound<div class="brieflinkpopdesc">PubChem Compound links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=medgen&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_medgen&amp;IdsFromResult=3056523" ref="reftype=MedGen&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">MedGen</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-55" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">MedGen<div class="brieflinkpopdesc">Related information in MedGen</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/20739919/" ref="reftype=PubMed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">PubMed</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-57" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=pcsubstance&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pcsubstance&amp;IdsFromResult=3056523" ref="reftype=Substance&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Substance&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Substance</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-59" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Substance<div class="brieflinkpopdesc">PubChem Substance links</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" toggles="ui-portlet_content-61" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-61" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="">
<div class="action">
<a href="javascript:historyDisplayState(&#39;ClearHT&#39;)">Clear</a><a href="javascript:historyDisplayState(&#39;HTOff&#39;)" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState(&#39;HTOn&#39;)" class="HTOff">Turn On</a>
</div>
<ul id="activity">
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c281bf2911de5257d9e76">Accurate Prediction of Dose-Dependent CYP3A4 Inhibition by Itraconazole and Its ...</a><div class="ralinkpop offscreen_noflow">Accurate Prediction of Dose-Dependent CYP3A4 Inhibition by Itraconazole and Its Metabolites From In Vitro Inhibition Data<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2010 Oct; 88(4)499</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_qry two_line">
<a class="htb" ref="log$=activity&amp;linkpos=2" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2818f0c03b7981758e9c">PMC3056523 <span class="number">(1)</span></a><div class="tertiary">PMC</div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=3" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c280304fcfad59176c25b">Potential impact of cytochrome P450 3A5 in human liver on drug interactions with...</a><div class="ralinkpop offscreen_noflow">Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles<div class="brieflinkpopdesc">British Journal of Clinical Pharmacology. 2010 Jun; 69(6)593</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_qry two_line">
<a class="htb" ref="log$=activity&amp;linkpos=4" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c28007fd84438f0ea0c37">PMC2883751 <span class="number">(1)</span></a><div class="tertiary">PMC</div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=5" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c27ef04fcfad59176bea1">Differential Effects of Tipranavir plus Ritonavir on Atorvastatin or Rosuvastati...</a><div class="ralinkpop offscreen_noflow">Differential Effects of Tipranavir plus Ritonavir on Atorvastatin or Rosuvastatin Pharmacokinetics in Healthy Volunteers <div class="brieflinkpopdesc">Antimicrobial Agents and Chemotherapy. 2009 Oct; 53(10)4385</div>
</div>
<div class="tertiary"></div>
</li>
</ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState(&#39;HTOn&#39;)">Turn recording back on</a></p>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--P2" name="crb--P2" rid="P2" style="position: absolute; visibility: visible; width: 370px; top: 801px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-63"><ul>
<li class="two_line" reference_id="R1">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/19216580/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Qualitative analysis of the role of metabolites in inhibitory drug-drug interactions: literature evaluation based on the metabolism and transport drug interaction database.</a><span class="one_line_source">[Chem Res Toxicol.  2009]</span><div class="alt-note">
<div class="authors">Isoherranen N, Hachad H, Yeung CK, Levy RH</div>
<div class="citation">Chem Res Toxicol. 2009 Feb; 22(2):294-8.</div>
</div>
</li>
<li class="two_line" reference_id="R3">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15242978/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Role of itraconazole metabolites in CYP3A4 inhibition.</a><span class="one_line_source">[Drug Metab Dispos.  2004]</span><div class="alt-note">
<div class="authors">Isoherranen N, Kunze KL, Allen KE, Nelson WL, Thummel KE</div>
<div class="citation">Drug Metab Dispos. 2004 Oct; 32(10):1121-31.</div>
</div>
</li>
<li class="two_line" reference_id="R4">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/8355218/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Interaction of the enantiomers of fluoxetine and norfluoxetine with human liver cytochromes P450.</a><span class="one_line_source">[J Pharmacol Exp Ther.  1993]</span><div class="alt-note">
<div class="authors">Stevens JC, Wrighton SA</div>
<div class="citation">J Pharmacol Exp Ther. 1993 Aug; 266(2):964-71.</div>
</div>
</li>
<li class="two_line" reference_id="R5">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18420781/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction.</a><span class="one_line_source">[Drug Metab Dispos.  2008]</span><div class="alt-note">
<div class="authors">Reese MJ, Wurm RM, Muir KT, Generaux GT, St John-Williams L, McConn DJ</div>
<div class="citation">Drug Metab Dispos. 2008 Jul; 36(7):1198-201.</div>
</div>
</li>
<li class="two_line" reference_id="R6" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/8195463/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine.</a><span class="one_line_source">[J Clin Psychopharmacol.  1994]</span><div class="alt-note">
<div class="authors">Preskorn SH, Alderman J, Chung M, Harrison W, Messig M, Harris S</div>
<div class="citation">J Clin Psychopharmacol. 1994 Apr; 14(2):90-8.</div>
</div>
</li>
<li class="two_line" reference_id="R7" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/14610241/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Atomoxetine hydrochloride: clinical drug-drug interaction prediction and outcome.</a><span class="one_line_source">[J Pharmacol Exp Ther.  2004]</span><div class="alt-note">
<div class="authors">Sauer JM, Long AJ, Ring B, Gillespie JS, Sanburn NP, DeSante KA, Petullo D, VandenBranden MR, Jensen CB, Wrighton SA, Smith BP, Read HA, Witcher JW</div>
<div class="citation">J Pharmacol Exp Ther. 2004 Feb; 308(2):410-8.</div>
</div>
</li>
</ul><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P3" name="crb--P3" rid="P3" style="position: absolute; visibility: visible; width: 370px; top: 1032px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-64"><ul>
<li class="two_line" reference_id="R8">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17495874/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo.</a><span class="one_line_source">[Clin Pharmacol Ther.  2008]</span><div class="alt-note">
<div class="authors">Templeton IE, Thummel KE, Kharasch ED, Kunze KL, Hoffer C, Nelson WL, Isoherranen N</div>
<div class="citation">Clin Pharmacol Ther. 2008 Jan; 83(1):77-85.</div>
</div>
</li>
<li class="two_line" reference_id="R3">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15242978/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Role of itraconazole metabolites in CYP3A4 inhibition.</a><span class="one_line_source">[Drug Metab Dispos.  2004]</span><div class="alt-note">
<div class="authors">Isoherranen N, Kunze KL, Allen KE, Nelson WL, Thummel KE</div>
<div class="citation">Drug Metab Dispos. 2004 Oct; 32(10):1121-31.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P4" name="crb--P4" rid="P4" style="position: absolute; visibility: visible; width: 370px; top: 1385px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-65"><ul><li class="two_line" reference_id="R3">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15242978/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Role of itraconazole metabolites in CYP3A4 inhibition.</a><span class="one_line_source">[Drug Metab Dispos.  2004]</span><div class="alt-note">
<div class="authors">Isoherranen N, Kunze KL, Allen KE, Nelson WL, Thummel KE</div>
<div class="citation">Drug Metab Dispos. 2004 Oct; 32(10):1121-31.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P8" name="crb--P8" rid="P8" style="position: absolute; visibility: visible; width: 370px; top: 2711px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-66"><ul><li class="two_line" reference_id="R3">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15242978/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Role of itraconazole metabolites in CYP3A4 inhibition.</a><span class="one_line_source">[Drug Metab Dispos.  2004]</span><div class="alt-note">
<div class="authors">Isoherranen N, Kunze KL, Allen KE, Nelson WL, Thummel KE</div>
<div class="citation">Drug Metab Dispos. 2004 Oct; 32(10):1121-31.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P14" name="crb--P14" rid="P14" style="position: absolute; visibility: visible; width: 370px; top: 4483px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-67"><ul>
<li class="two_line" reference_id="R9">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/8623953/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The effects of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.</a><span class="one_line_source">[Anesth Analg.  1996]</span><div class="alt-note">
<div class="authors">Olkkola KT, Ahonen J, Neuvonen PJ</div>
<div class="citation">Anesth Analg. 1996 Mar; 82(3):511-6.</div>
</div>
</li>
<li class="two_line" reference_id="R11">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/8527290/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers.</a><span class="one_line_source">[Br J Clin Pharmacol.  1995]</span><div class="alt-note">
<div class="authors">Ahonen J, Olkkola KT, Neuvonen PJ</div>
<div class="citation">Br J Clin Pharmacol. 1995 Sep; 40(3):270-2.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P15" name="crb--P15" rid="P15" style="position: absolute; visibility: visible; width: 370px; top: 4649px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-68"><ul><li class="two_line" reference_id="R12">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/8841155/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The effect of ingestion time interval on the interaction between itraconazole and triazolam.</a><span class="one_line_source">[Clin Pharmacol Ther.  1996]</span><div class="alt-note">
<div class="authors">Neuvonen PJ, Varhe A, Olkkola KT</div>
<div class="citation">Clin Pharmacol Ther. 1996 Sep; 60(3):326-31.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P16" name="crb--P16" rid="P16" style="position: absolute; visibility: visible; width: 370px; top: 4940px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-69"><ul>
<li class="two_line" reference_id="R13">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/9591931/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin.</a><span class="one_line_source">[Eur J Clin Pharmacol.  1998]</span><div class="alt-note">
<div class="authors">Backman JT, Kivistö KT, Olkkola KT, Neuvonen PJ</div>
<div class="citation">Eur J Clin Pharmacol. 1998 Mar; 54(1):53-8.</div>
</div>
</li>
<li class="two_line" reference_id="R8">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17495874/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo.</a><span class="one_line_source">[Clin Pharmacol Ther.  2008]</span><div class="alt-note">
<div class="authors">Templeton IE, Thummel KE, Kharasch ED, Kunze KL, Hoffer C, Nelson WL, Isoherranen N</div>
<div class="citation">Clin Pharmacol Ther. 2008 Jan; 83(1):77-85.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P18" name="crb--P18" rid="P18" style="position: absolute; visibility: visible; width: 370px; top: 5390px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-70"><ul>
<li class="two_line" reference_id="R14">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/14529369/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Relationship between extent of inhibition and inhibitor dose: literature evaluation based on the metabolism and transport drug interaction database.</a><span class="one_line_source">[Curr Drug Metab.  2003]</span><div class="alt-note">
<div class="authors">Levy RH, Hachad H, Yao C, Ragueneau-Majlessi I</div>
<div class="citation">Curr Drug Metab. 2003 Oct; 4(5):371-80.</div>
</div>
</li>
<li class="two_line" reference_id="R12">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/8841155/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The effect of ingestion time interval on the interaction between itraconazole and triazolam.</a><span class="one_line_source">[Clin Pharmacol Ther.  1996]</span><div class="alt-note">
<div class="authors">Neuvonen PJ, Varhe A, Olkkola KT</div>
<div class="citation">Clin Pharmacol Ther. 1996 Sep; 60(3):326-31.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P19" name="crb--P19" rid="P19" style="position: absolute; visibility: visible; width: 370px; top: 5554px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-71"><ul><li class="two_line" reference_id="R15">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12695344/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Comparison of in vitro and in vivo inhibition potencies of fluvoxamine toward CYP2C19.</a><span class="one_line_source">[Drug Metab Dispos.  2003]</span><div class="alt-note">
<div class="authors">Yao C, Kunze KL, Trager WF, Kharasch ED, Levy RH</div>
<div class="citation">Drug Metab Dispos. 2003 May; 31(5):565-71.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P25" name="crb--P25" rid="P25" style="position: absolute; visibility: visible; width: 370px; top: 7027px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-72"><ul><li class="two_line" reference_id="R8">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17495874/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo.</a><span class="one_line_source">[Clin Pharmacol Ther.  2008]</span><div class="alt-note">
<div class="authors">Templeton IE, Thummel KE, Kharasch ED, Kunze KL, Hoffer C, Nelson WL, Isoherranen N</div>
<div class="citation">Clin Pharmacol Ther. 2008 Jan; 83(1):77-85.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P30" name="crb--P30" rid="P30" style="position: absolute; visibility: visible; width: 370px; top: 8066px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-73"><ul>
<li class="two_line" reference_id="R3">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15242978/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Role of itraconazole metabolites in CYP3A4 inhibition.</a><span class="one_line_source">[Drug Metab Dispos.  2004]</span><div class="alt-note">
<div class="authors">Isoherranen N, Kunze KL, Allen KE, Nelson WL, Thummel KE</div>
<div class="citation">Drug Metab Dispos. 2004 Oct; 32(10):1121-31.</div>
</div>
</li>
<li class="two_line" reference_id="R16">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/16192315/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions.</a><span class="one_line_source">[J Pharmacol Exp Ther.  2006]</span><div class="alt-note">
<div class="authors">Obach RS, Walsky RL, Venkatakrishnan K, Gaman EA, Houston JB, Tremaine LM</div>
<div class="citation">J Pharmacol Exp Ther. 2006 Jan; 316(1):336-48.</div>
</div>
</li>
<li class="two_line" reference_id="R8">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17495874/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo.</a><span class="one_line_source">[Clin Pharmacol Ther.  2008]</span><div class="alt-note">
<div class="authors">Templeton IE, Thummel KE, Kharasch ED, Kunze KL, Hoffer C, Nelson WL, Isoherranen N</div>
<div class="citation">Clin Pharmacol Ther. 2008 Jan; 83(1):77-85.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P32" name="crb--P32" rid="P32" style="position: absolute; visibility: visible; width: 370px; top: 8726px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-74"><ul>
<li class="two_line" reference_id="R16">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/16192315/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions.</a><span class="one_line_source">[J Pharmacol Exp Ther.  2006]</span><div class="alt-note">
<div class="authors">Obach RS, Walsky RL, Venkatakrishnan K, Gaman EA, Houston JB, Tremaine LM</div>
<div class="citation">J Pharmacol Exp Ther. 2006 Jan; 316(1):336-48.</div>
</div>
</li>
<li class="two_line" reference_id="R17" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/8689807/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">First-pass metabolism of midazolam by the human intestine.</a><span class="one_line_source">[Clin Pharmacol Ther.  1996]</span><div class="alt-note">
<div class="authors">Paine MF, Shen DD, Kunze KL, Perkins JD, Marsh CL, McVicar JP, Barr DM, Gillies BS, Thummel KE</div>
<div class="citation">Clin Pharmacol Ther. 1996 Jul; 60(1):14-24.</div>
</div>
</li>
</ul><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P46" name="crb--P46" rid="P46" style="display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-75"><ul>
<li class="expanded" reference_id="R3">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15242978/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Role of itraconazole metabolites in CYP3A4 inhibition.</a><span class="one_line_source">[Drug Metab Dispos.  2004]</span><div class="alt-note">
<div class="authors">Isoherranen N, Kunze KL, Allen KE, Nelson WL, Thummel KE</div>
<div class="citation">Drug Metab Dispos. 2004 Oct; 32(10):1121-31.</div>
</div>
</li>
<li class="expanded" reference_id="R8">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17495874/" ref="reftype=pubmed&amp;article-id=3056523&amp;issue-id=195058&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo.</a><span class="one_line_source">[Clin Pharmacol Ther.  2008]</span><div class="alt-note">
<div class="authors">Templeton IE, Thummel KE, Kharasch ED, Kunze KL, Hoffer C, Nelson WL, Isoherranen N</div>
<div class="citation">Clin Pharmacol Ther. 2008 Jan; 83(1):77-85.</div>
</div>
</li>
</ul></div>
</div>
</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="./PMC3056523_files/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"><div id="body-link-popper-R1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Qualitative analysis of the role of metabolites in inhibitory drug-drug interactions: literature evaluation based on the metabolism and transport drug interaction database.<div class="authors">Isoherranen N, Hachad H, Yeung CK, Levy RH</div><div class="citation">Chem Res Toxicol. 2009 Feb; 22(2):294-8.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/19216580/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R1">Ref list</a>]</p></div><div id="body-link-popper-R2" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">2. <span class="citation">Fujioka Y, Yeung CK, Hachad H, Levy RH, Isoherranen N. Analysis of the contribution of circulating metabolites to inhibitory drug-drug interactions: literature evaluation based on the metabolism and transport drug interaction database. <span><span class="ref-journal">Drug Metab Rev. </span>2009;<span class="ref-vol">41</span>(suppl. 3):69.</span></span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R2">Ref list</a>]</div><div id="body-link-popper-R3" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Role of itraconazole metabolites in CYP3A4 inhibition.<div class="authors">Isoherranen N, Kunze KL, Allen KE, Nelson WL, Thummel KE</div><div class="citation">Drug Metab Dispos. 2004 Oct; 32(10):1121-31.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15242978/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R3">Ref list</a>]</p></div><div id="body-link-popper-R4" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Interaction of the enantiomers of fluoxetine and norfluoxetine with human liver cytochromes P450.<div class="authors">Stevens JC, Wrighton SA</div><div class="citation">J Pharmacol Exp Ther. 1993 Aug; 266(2):964-71.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8355218/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R4">Ref list</a>]</p></div><div id="body-link-popper-R5" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction.<div class="authors">Reese MJ, Wurm RM, Muir KT, Generaux GT, St John-Williams L, McConn DJ</div><div class="citation">Drug Metab Dispos. 2008 Jul; 36(7):1198-201.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18420781/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R5">Ref list</a>]</p></div><div id="body-link-popper-R6" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine.<div class="authors">Preskorn SH, Alderman J, Chung M, Harrison W, Messig M, Harris S</div><div class="citation">J Clin Psychopharmacol. 1994 Apr; 14(2):90-8.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8195463/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R6">Ref list</a>]</p></div><div id="body-link-popper-R7" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Atomoxetine hydrochloride: clinical drug-drug interaction prediction and outcome.<div class="authors">Sauer JM, Long AJ, Ring B, Gillespie JS, Sanburn NP, DeSante KA, Petullo D, VandenBranden MR, Jensen CB, Wrighton SA, Smith BP, Read HA, Witcher JW</div><div class="citation">J Pharmacol Exp Ther. 2004 Feb; 308(2):410-8.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/14610241/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R7">Ref list</a>]</p></div><div id="body-link-popper-R8" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo.<div class="authors">Templeton IE, Thummel KE, Kharasch ED, Kunze KL, Hoffer C, Nelson WL, Isoherranen N</div><div class="citation">Clin Pharmacol Ther. 2008 Jan; 83(1):77-85.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17495874/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R8">Ref list</a>]</p></div><div id="body-link-popper-R9" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The effects of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.<div class="authors">Olkkola KT, Ahonen J, Neuvonen PJ</div><div class="citation">Anesth Analg. 1996 Mar; 82(3):511-6.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8623953/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R9">Ref list</a>]</p></div><div id="body-link-popper-R11" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers.<div class="authors">Ahonen J, Olkkola KT, Neuvonen PJ</div><div class="citation">Br J Clin Pharmacol. 1995 Sep; 40(3):270-2.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8527290/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R11">Ref list</a>]</p></div><div id="body-link-popper-R12" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The effect of ingestion time interval on the interaction between itraconazole and triazolam.<div class="authors">Neuvonen PJ, Varhe A, Olkkola KT</div><div class="citation">Clin Pharmacol Ther. 1996 Sep; 60(3):326-31.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8841155/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R12">Ref list</a>]</p></div><div id="body-link-popper-R13" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin.<div class="authors">Backman JT, Kivistö KT, Olkkola KT, Neuvonen PJ</div><div class="citation">Eur J Clin Pharmacol. 1998 Mar; 54(1):53-8.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9591931/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R13">Ref list</a>]</p></div><div id="body-link-popper-R14" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Relationship between extent of inhibition and inhibitor dose: literature evaluation based on the metabolism and transport drug interaction database.<div class="authors">Levy RH, Hachad H, Yao C, Ragueneau-Majlessi I</div><div class="citation">Curr Drug Metab. 2003 Oct; 4(5):371-80.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/14529369/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R14">Ref list</a>]</p></div><div id="body-link-popper-R15" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Comparison of in vitro and in vivo inhibition potencies of fluvoxamine toward CYP2C19.<div class="authors">Yao C, Kunze KL, Trager WF, Kharasch ED, Levy RH</div><div class="citation">Drug Metab Dispos. 2003 May; 31(5):565-71.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12695344/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R15">Ref list</a>]</p></div><div id="body-link-popper-R16" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions.<div class="authors">Obach RS, Walsky RL, Venkatakrishnan K, Gaman EA, Houston JB, Tremaine LM</div><div class="citation">J Pharmacol Exp Ther. 2006 Jan; 316(1):336-48.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16192315/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R16">Ref list</a>]</p></div><div id="body-link-popper-R17" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">First-pass metabolism of midazolam by the human intestine.<div class="authors">Paine MF, Shen DD, Kunze KL, Perkins JD, Marsh CL, McVicar JP, Barr DM, Gillies BS, Thummel KE</div><div class="citation">Clin Pharmacol Ther. 1996 Jul; 60(1):14-24.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8689807/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#R17">Ref list</a>]</p></div></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <div class="breadcrumbs">You are here: 
            <span id="breadcrumb_text"><a href="http://www.ncbi.nlm.nih.gov/guide/">NCBI</a> &gt; <a href="http://www.ncbi.nlm.nih.gov/guide/literature/">Literature</a> &gt; <a href="http://www.ncbi.nlm.nih.gov/pmc/">PubMed Central (PMC)</a></span></div>
    <a id="help-desk-link" class="help_desk jig-ncbihelpwindow" target="_blank" href="http://www.ncbi.nlm.nih.gov/sites/ehelp?&amp;Ncbi_App=pmc&amp;Db=pmc&amp;Page=literature&amp;Snapshot=/projects/PMC/PMCViewer@4.35&amp;Time=2016-06-23T14:19:07-04:00&amp;Host=ptpmc101">Write to the Help Desk</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="./PMC3056523_files/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="http://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="http://www.nlm.nih.gov/" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="http://www.nih.gov/" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="http://www.dhhs.gov/" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="http://www.usa.gov/" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            
            <a href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html">Copyright</a> | <a href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html#disclaimer">Disclaimer</a> |
            <a href="http://www.nlm.nih.gov/privacy.html" class="newdomain">Privacy</a> | 
            <a href="http://www.ncbi.nlm.nih.gov/guide/browsers/">Browsers</a> | <a href="http://www.nlm.nih.gov/accessibility.html">Accessibility</a> | <a href="http://www.ncbi.nlm.nih.gov/About/glance/contact_info.html">Contact</a>
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="http://www.ncbi.nlm.nih.gov/">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url"><a href="http://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
        </div>
    </div>
    <script type="text/javascript" src="./PMC3056523_files/InstrumentPageStarterJS.js"> </script>    
    <script type="text/javascript" src="./PMC3056523_files/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="http://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div><div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 63.5938px; left: 408.188px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: none;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056523/#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: none;">Turn off</a></div></div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript>&lt;img alt="statistics" src="/stat?jsdisabled=true&amp;amp;ncbi_db=pmc&amp;amp;ncbi_pdid=article&amp;amp;ncbi_acc=&amp;amp;ncbi_domain=nihpa&amp;amp;ncbi_report=record&amp;amp;ncbi_type=fulltext&amp;amp;ncbi_objectid=&amp;amp;ncbi_pcid=/articles/PMC3056523/&amp;amp;ncbi_app=pmc" /&gt;</noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- F4FC7E8376854741_0014SID /projects/PMC/PMCViewer@4.35 ptpmc101 v4.1.r480124 Mon, Sep 28 2015 02:46:19 -->

<script type="text/javascript" src="./PMC3056523_files/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1" style="display: none;"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div><ul class="print-log"><li></li></ul><div style="position: absolute; width: 0px; height: 0px; overflow: hidden; padding: 0px; border: 0px; margin: 0px;"><div id="MathJax_Font_Test" style="position: absolute; visibility: hidden; top: 0px; left: 0px; width: auto; padding: 0px; border: 0px; margin: 0px; white-space: nowrap; text-align: left; text-indent: 0px; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; font-size: 40px; font-weight: normal; font-style: normal; font-family: STIXSizeOneSym, sans-serif;"></div></div><div class="ui-ncbipopper-arrow-image ui-ncbipopper-arrow-right" style="display: none; top: -100px; left: -100px; opacity: 1;">&nbsp;</div><div class="ui-ncbipopper-arrow-image ui-ncbipopper-arrow-right" style="display: none; top: -100px; left: -100px; opacity: 1;">&nbsp;</div></body></html>